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Abstract 
Magnetic resonance imaging (MRI) studies have shown the brains of schizophrenia 
patients to have smaller hippocampi, larger ventricles, and reduced cortical thickness 
and regional brain volumes, as compared to the brains of mentally healthy subjects. 
The abnormal brain morphology may reflect subtle deviances from normal brain 
development. Early adverse somatic events, in the current thesis studied in the form 
of obstetric complications (OCs), in the pre-, peri-, or postnatal periods can cause or 
influence a deviant neurodevelopment. In scientific studies, it has been demonstrated 
that occurrence of OCs increase the risk of schizophrenia. Moreover, results from 
experimental animal studies demonstrate that different OCs cause both abnormal 
changes in brain morphology and behaviour that parallel what is observed in 
schizophrenia. In humans, OCs have been related to smaller hippocampi, larger 
lateral ventricles, and reduced cortical volume in schizophrenia patients with as 
compared to patients without a history of OCs. Taken together, these findings suggest 
that early somatic trauma such as OCs may exert an influence on neurodevelopment, 
detectable in the brain decades later.  
The main aim of this PhD thesis was to investigate the relationship between a history 
of (OCs) and brain morphology in patients with schizophrenia. The subaims were to 
study 1) if such a putative effect could explain some of the differences in brain 
morphology observed between schizophrenia patients and healthy controls, and 2) if 
the effect of OCs on hippocampal volume, if demonstrated, is modified by genetic 
variation (allele variation in single nucleotide polymorphisms). 
The subject sample included in the current four studies comprises 54 schizophrenia 
patients and 54 healthy control subjects. They all underwent clinical examination, 
genotyping, and MRI scanning at the Karolinska Institutet and Karolinska University 
Hospital in Stockholm, Sweden. Automated software tools were used to obtain 
measures of basal ganglia nuclei and hippocampal volumes, cortical thickness, and 
cortical folding patterns. Information on OCs was independently collected from 
original birth records.  
The main findings were that OCs are not associated with basal ganglia volumes (study 
I) or cortical thickness (study II), but significantly associated with reduced cortical 
folding in the left pars triangularis (Broca’s area) (study III) and with altered 
hippocampal volumes (study IV). The effect of OCs on hippocampal volume appeared 
to be modulated by allele variation in the hypoxia-regulated GRM3 gene (study IV). 
Furthermore, schizophrenia patients did not differ from healthy control subjects with 
respect to the rate or severity of OCs per se; the effects of OCs on basal ganglia 
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volumes, cortical thickness, and cortical gyrification; or the gene*OCs interaction 
effect on hippocampal volume. 
In conclusion, while some brain structures (cortical thickness, basal ganglia volumes) 
were unaffected by a history OCs, OCs influenced other aspects of brain morphology 
(hippocampal volume, cortical folding) in the same way in both patients with 
schizophrenia and healthy controls. The differences in brain morphology found 
between schizophrenia patients and healthy controls were not effects of OCs. Genetic 
variation may modulate the effect of OCs on hippocampal volume. 
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Definitions: 
Morphology:  
a) The branch of biology that deals with the form and structure of organisms without 
consideration of function. b) The form and structure of an organism or one of its 
parts: the morphology of a cell; the morphology of vertebrates. 
        (Encyclopaedia Britannica) 
Obstetric complications: 
‘‘...the broad class of somatic deviations from an expected, normal course of events 
and offspring development during pregnancy, labour-delivery, and the early neonatal 
period” 
                  (McNeil, 1999) 
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1. Background 
1.1 Schizophrenia 
Schizophrenia is a severe mental illness with a prevalence of about 0.7-1%  worldwide 
(Gottesman, 1991;Saha et al., 2005). The diagnosis of schizophrenia is descriptive and 
comprises a broad range of symptoms and clinical manifestations. Schizophrenia as 
an illness entity was first described by the German psychiatrist Emil Kraepelin 
(Kraepelin, 1896) as dementia praecox; a name implicating a chronic degeneration 
syndrome with poor prognosis. The term schizophrenia meaning “splitting of the 
feeling” (Blom, 2003) was introduced by the Swiss psychiatrist Eugen Bleuler to 
describe the core feature of the illness, the “splitting of psychic functions” (Bleuler, 
1911). Today, according to the DSM-IV (American psychiatric association, 1994), a 
diagnosis of schizophrenia is based on a combination of several symptoms: 
a) two or more of the following symptoms have been present for a month or more: 
hallucinations, delusions, disorganized speech, disorganized behaviour and/or 
negative symptoms (affective flattening, apathy).  
b) decline in function lasting a minimum of 6 months 
c) no developmental disorder 
d) schizoaffective disorder has been ruled out 
e) no organic cause or drugs that cause the symptoms. 
Dopamine and glutamate disturbances are considered to be the core underlying 
pathophysiological mechanisms of the illness (Keshavan et al., 2008;Stone et al., 
2007). The locus of dopamine dysregulation appears to be at the presynaptic 
dopaminergic control level in regionally specific pattern including prefrontal 
hypodopaminergia and a subcortical hyperdopaminergia (Howes & Kapur, 2009). 
Brain morphological aberrations in schizophrenia have been reported from in vivo (CT 
and MRI) (Chua & McKenna, 1995;Ellison-Wright & Bullmore, 2009;Glahn et al., 
2008;Honea et al., 2005;Malla et al., 2002;Shenton et al., 2001;Steen et al., 2006) and 
post mortem studies (Benes, 1988;Bernstein et al., 2009). However, neuropathological 
changes in schizophrenia are subtle, and no pathognomonic lesions have been 
demonstrated (Keshavan et al., 2008).  
The concise aetiology of schizophrenia is hitherto unknown. The illness has a strong 
genetic component, with an estimated heritability up to 80% (Sullivan et al., 2003). 
Multiple environmental effects modify schizophrenia liability. The environmental risk 
factors include urban birth (Harrison et al., 2003), paternal age (Byrne et al., 
2003;Miller et al., 2010;Zammit et al., 2003), migration (Selten et al., 2007;Cantor-
Graae, 2007), social disadvantage (Wicks et al., 2005), cannabis use (Hall & 
Degenhardt, 2008), stressful life events (Miller et al., 2001;van et al., 2008), and pre- 
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and perinatal adversities (Cannon et al., 2002a;Dalman et al., 2001;Geddes et al., 
1999;Hultman et al., 1999;Nilsson et al., 2005;Rosso et al., 2000). The high degree of 
heritability, combined with findings of several environmental risk factors suggest that 
gene-environment interactions are of importance to the development of schizophrenia.  
Over a hundred years of schizophrenia research have contributed to the 
understanding of schizophrenia as an illness with biological correlates. Some of these 
correlates (e.g. brain morphological alterations) have been suggested to have their 
origin in disturbed neurodevelopment (Fatemi & Folsom, 2009;Lewis & Murray, 
1987;Weinberger, 1987).    
 
1.2 Neurodevelopment  
Prenatal neurodevelopment follows a highly complex pattern and is under strong 
genetic influence (Arnold & Rioux, 2001;Hatten, 2002). The development of the neural 
system starts when the cells in the embryonic ectoderm form the neural plate; the 
neural plate then folds to form the neural tube (Jain et al., 2001). The cavity of the 
neural tube is the early rudiment of the cerebral ventricles, and the “walls” of the 
neural tube is lined with neuroepithelial cells (the ventricular zone) that later develops 
into neurons and glia (Arnold & Rioux, 2001).  
Subdivision of the neuroepithelial cells in the neural tube into different regions give 
rise to the forebrain, midbrain and hindbrain (Klempan et al., 2004) (see figure 1). 
 
Figure 1. Developmental origin of different brain structures, schematic. 
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Eight stages in the developing brain has been described (Mayes & Ward, 2003); neural 
plate induction, neuronal and glial cell proliferation (occurring in the 2nd to 4th foetal 
month for neurons and in the 5th foetal month to one year postnatally for glial cells), 
cell migration (third to fifth foetal month), cell aggregation, neuronal maturation, 
neuronal connectivity including synaptogenesis, cell death, and pruning, from the 6th 
gestational month and several years postnatally.  
Migration from the ventricular zone to the cortex occurs in an inward-out fashion. The 
first neurons to migrate constitute the inner layer of the mature cortex, and the latest 
neurons to migrate constitute the outer layer (Angevine, Jr. & Sidman, 1961;Batra et 
al., 2009). The neural migration to the cortex is position specific (Rakic, 2007). The 
migration is radially oriented and guided by glial cells to form columnar arrangements 
(Hatten, 2002;Rakic, 2007). In addition, a different pattern of tangential migration, in 
a ventral to dorsal fashion, is followed by interneurons and precede their radial 
organization into columnar shafts (Ang, Jr. et al., 2003;Wichterle et al., 2001). The 
majority of the interneurons are generated in the subventricular zone (Letinic et al., 
2002). Disturbances in the processes of neuronal proliferation or migration lead to 
malpositioning of the neurons within the cortex which might prevent formation of the 
appropriate connections and adversely affect mature brain function (Clunic, 2009).  
Cortical folding or gyrification develops alongside the cortical migration. The early 
stages of gyrification appear around gestational week 16, with a rapid increase in 
cortical gyrification in the third trimester of pregnancy (Armstrong et al., 1995). The 
human gyrification process appear to be a result of tension based mechanisms. Visco-
elastic tension exerted by cortical fibres is considered to draw regions with greater 
connectivity closer together (forming gyri) and thereby reduces the transit time of the 
action potentials (Van Essen, 1997;White et al., 2010). The primary sulci appear 
almost similar in all humans, whereas secondary and tertiary sulci display greater 
inter subject variety (Armstrong et al., 1995). 
Striatal development starts at the 6th gestational week. From the floor of the 
telencephalic vesicle it bulges into the lateral ventricle (Jain et al., 2001), and divides 
into the medial and lateral striatum separated by the capsula interna at a later stage. 
The early rudiments of the hippocampus develop from the pallium at the rostral end 
of the lateral ventricle, before moving caudally as the di- and telencephalon coalesce 
(Brodal, 2001).  
 
1.3 The neurodevelopmental hypothesis of schizophrenia 
The foetal origin health concept describe a relationship between signs of in utero 
compromise  (e.g. low birth weight) and later development of somatic disorders such 
as coronary heart disease, stroke, and diabetes (Barker et al., 1993;Gluckman et al., 
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2008). Findings from epidemiologic and experimental studies are supportive of a foetal 
origin of mental illnesses such as autism, ADHD, personality disorders, and 
schizophrenia (Beydoun & Saftlas, 2008;Larsson et al., 2005;Schlotz & Phillips, 
2009;Thompson et al., 2010). 
The first description of early somatic trauma and neurodevelopmental disturbances as 
putative risk factors for schizophrenia dates back to Rosanoffs classic twin study “The 
etiology of the so called schizophrenic psychoses” from 1934. Although the twin 
concordance rates were the main objective of this study, he discussed the possibility 
of schizophrenia being a ”decerebration syndrome which may result from birth trauma” 
(Rosanoff et al., 1934), based on the finding that birth trauma such as prematurity 
and the use of forceps were more frequent in the ill than in the healthy twins. 
The concept was, however, no focus of research interest before Pasamanick et al’s 
theory of a ”continuum of reproductive causality” (Pasamanick et al., 1956). According 
to this theory, pre- and perinatal adversities, depending on their severity, could cause 
harm ranging from death and severe mental and physical impairment to behavioural 
deviances and psychiatric illness in the offspring. The theory opened a new research 
ground (see Cannon et al., 2002a for review). Regarding the impact of pre and 
perinatal adversities on schizophrenia risk, a “break through” came with the finding of 
significantly lower birth weight in schizophrenia subjects than in healthy controls 
(Lane & Albee, 1966). The interaction between genetic (heritability) and environmental 
factors (OCs) on schizophrenia risk was demonstrated by Mednick & McNeil, who 
studied the offspring of mothers with schizophrenia (Mednick & McNeil, 1968). 
Neuropathological examinations of post mortem brain tissue from schizophrenia 
patients have revealed alterations such as ectopic grey matter (sign of aberrant 
prenatal neuronal migration) (Jakob & Beckmann, 1986;Nopoulos et al., 
1998;Nopoulos et al., 1995), and absence of gliosis1 (lack of degenerative processes) 
(Bogerts, 1999). These findings do not support schizophrenia as a neurodegenerative 
syndrome (as suggested in the Kraepelinean tradition), but suggest that schizophrenia 
could be an illness related to disrupted neurodevelopment (Rapoport et al., 2005). 
Additional support for a neurodevelopmental origin of the illness come from studies 
that report an increased occurrence of minor physical anomalies (MPA) (Lloyd et al., 
2008;McNeil & Cantor-Graae, 2000) and neurological soft signs (Compton et al., 2007) 
in schizophrenia patents. MPAs such as low set ears and epicanthal eye folds have 
their developmental origin in the embryonal ectoderm, as has the brain neuronal 
tissue. The fact that many schizophrenia patients display neurocognitive 
abnormalities during childhood and adolescence (Sorensen et al., 2010;Woodberry et 
                                                 
1 Gliosis  describe  elevated glial cell density as is present in progressive brain diseases 
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al., 2008;Reichenberg et al., 2006), before illness onset, is further support for a 
neurodevelopmental origin of the illness.  
The conceptualization of schizophrenia as a neurodevelopmental illness proved to be a 
fruitful framework for further research (Lewis & Murray, 1987;Weinberger, 1987), and 
the hypothesis has later been supported by numerous register based-, clinical case 
control-, MRI-, molecular genetic-, and animal model studies. This research provided 
the fundament for the hypotheses examined in the four studies included in this 
thesis. 
 
1.4 Studies of pre-and perinatal risk factors in the development of schizophrenia 
Many epidemiological but also clinical studies have demonstrated an association 
between early somatic trauma occurring in the pre- and perinatal period and a later 
development of schizophrenia. Studies have also investigated the extent to which this 
increased prevalence may be caused by genetic factors in the offspring, by maternal 
socio-demographic factors and psychiatric health, or a combination.  
 
1.4.1 Maternal starvation  
At the end of World War II, between February and May 1945, severe hunger occurred 
in a region in the Netherlands. A significantly higher prevalence of schizophrenia was 
reported among children of women who were pregnant during the starvation period. In 
particular if starvation was severe and occured during the first trimester, the relative 
risk increase was 2.0 (Hoek et al., 1998). Similarly, offspring of women who were 
pregnant during the Chinese starvation between 1959 and 1961 also had a higher 
rate of schizophrenia (relative risk 2.3) (St Clair et al., 2005). Some evidence from 
animal models indicate that pro-inflammatory factors may mediate the effect of 
maternal under-nutrition on foetal brain development (Shen et al., 2008). 
 
1.4.2 Maternal infection 
The increased rate of schizophrenia in subjects born during late winter- / spring 
months has been attributed to maternal infection during pregnancy. Accordingly, 
evidence for an association between several infectious agents and increased risk for 
offspring schizophrenia has been put forward. Maternal influenza infection, as 
determined serologically by the use of frozen maternal plasma, has been associated 
with a seven fold increase in schizophrenia risk (Brown et al., 2004). In utero exposure 
to other viral infections such as measles (Torrey et al., 1988), rubella (Brown et al., 
2001), varicella-zoster (Torrey et al., 1988), herpes simplex virus 2 (Buka et al., 2008), 
but also toxoplasmosis (Mortensen et al., 2007) and bacterial infections (Sorensen et 
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al., 2009) has been linked to an increased risk for schizophrenia. Supportive of a 
gene-environment interaction model, an increased risk of developing schizophrenia 
after in utero exposure to maternal pyelonephritis was associated with a history of 
familial schizophrenia (Clarke et al., 2009). The variety of pathogens suggests that 
common underlying inflammatory responses may be of importance (Shi et al., 
2005;Smith et al., 2007). Prenatal immune challenge have been demonstrated to 
cause alterations in the dopamine metabolism (Meyer & Feldon, 2009;Winter et al., 
2009). 
 
1.4.3 Obstetric complications 
Large register-based studies have provided statistical evidence for a link between a 
variety of OCs and schizophrenia. Increased risk of schizophrenia in offspring of 
mothers who had suffered placental- or uterine bleeding, in boys with low birth 
weight, and in sons of mothers with grand multipara (>3 previous births) was reported 
from a Swedish study of 3942 subjects (Hultman et al., 1999). In a Finnish birth 
cohort study (n=25 865), schizophrenia was found to be related to to low birth weight 
(< 2500g), and to the combination of low birth weight and birth before gestational 
week 37 (Jones et al., 1998). Further evidence for an association between low birth 
weight (<2500g) and schizophrenia has been reported from a large twin study of 5680 
twin pairs of which 88 were diagnosed with schizophrenia (Nilsson et al., 2005) 
Low birth weight is indicative of intra-uterine compromise of the foetus occurring over 
an extended amount of time (Rehn et al., 2004). However, detrimental events related 
to birth have also been associated with increased schizophrenia risk. Perinatal 
asphyxia has been related to schizophrenia with an odds ratio of 4.4, after control for 
confounding factors such as other obstetric adversities, maternal history of psychosis, 
and social class (n=1567) (Dalman et al., 2001). The finding was partly replicated in a 
Danish register study (n=25 865) in which hypoxia, prematurity, and maternal 
infection were significantly related to schizophrenia after controlling for familial 
psychiatric illness and social class (Byrne et al., 2007). 
The variety of positive findings for specific OCs, taken together with scattered reports 
of null findings (Kendell et al., 2000;Onstad et al., 1992), have complicated efforts to 
integrate OCs and schizophrenia in a pathophysiological framework. A large meta-
analysis comprising eight studies including 1923 patients with schizophrenia and 527 
925 control subjects distinguished three categories of obstetric complications 
associated with schizophrenia (Cannon et al., 2002a): 1) complications of pregnancy 
(diabetes> rhesus incompatibility> bleeding> preeclampsia), 2) abnormal foetal 
development (low birth weight> congenital malformations> reduced head 
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circumference), and  3) complications of labour and delivery (emergency caesarean 
section> uterine atony> asphyxia).  
Foetal hypoxia may be the common underlying factor of the various complications 
(Verdoux & Sutter, 2002), as has been demonstrated in animal models, for review see 
(Boksa, 2004;Rees et al., 2008).  
Also pre-disposing socio-demographic factors associated with adverse pregnancy 
outcome may be confounded with a history of maternal mental illness (Ellman et al., 
2007;Jablensky et al., 2005). By this means, the offspring of mothers with 
schizophrenia may carry the increased risk of schizophrenia from both heritability 
risk and OCs. 
 
1.4.4  Animal models of obstetric complications in schizophrenia 
Animal models have been developed to explore how pre- and perinatal complications 
affect offspring brain morphology and neurodevelopment. Criteria for animal species 
to be used in models of human brain damage include the condition that a similar 
proportion of brain development must occur in utero; the insult can be delivered in 
utero at an equivalent stage of development identified to be vulnerable in humans; the 
volume of white to grey matter is similar to the human brain; the physiological 
outcome of the insult can be monitored; and neurobehavioural parameters can be 
tested postnatally (Rees et al., 2008). It is important to note that no animal fulfils all 
of these criteria. For instance, the rat brain at birth is less mature than the human 
brain at birth, whereas the maturity of the guinea pig brain is more similar to that of 
the brain of the human neonate (Boksa, 2004). 
Given the limitations of no animal fulfilling all criteria listed above, several 
experimental animal models of OCs effects have demonstrated resulting abnormalities 
of brain morphology (reviewed by Boksa, 2004); maternal diabetes has caused reduced 
brain weight in adult rats; intra-uterine growth restriction has caused enlarged 
ventricles, reduced hippocampal volume, and reduced cortical area in newborn guinea 
pigs and altered neuronal migration to the cortex in postnatal and postpubertal rats; 
neonatal viral infection has caused cortical thinning and reduced hippocampal cell 
number in adult rats; birth hypoxia has been linked to reduced hippocampal cell 
number in adult rats, reduced neurons in hypothalamus, striatum, and cerebellum as 
well as hippocampal and hypothalamic neurodegeneration in adult guinea pigs; 
maternal infection has been linked to hippocampal cell atrophy in adult mice (Fatemi 
et al., 2008) and reduced cortical grey matter volume in monkeys (Short et al., 2010).  
Animal models may also be used to measure alterations in neurotransmittors as a 
response to OCs. Of particular importance for schizophrenia research is the dopamine 
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metabolism. In different rat models, OCs have been demonstrated to cause altered 
dopamine-mediated behaviour (caesarean section) (Berger et al., 2000), altered 
dopamine receptor mRNA in the striatum (perinatal asphyxia) (Gross et al., 2005), 
decreased striatal dopamine turnover (caesarean section) and nucleus accumbens 
dopamine turnover (caesarean section + anoxia) (El-Khodor & Boksa, 1997), and 
greater neuronal spine density in the nucleus accumbens (caesarean section + anoxia) 
(Juarez et al., 2008)  
The nature of foetal neuropathology depends on the severity of the insult and the 
gestational age of the foetus (reviewed by Rees et al., 2008), as summarized below (1-
3). 
1. Acute insults in early gestation, when neurogenesis and neuronal migration is at its 
peak, results in death of e.g. pyramidal cells in the hippocampus, slowing of neuronal 
migration to the hippocampus, and diffuse white matter damage (Rees et al., 1999). 
2. Acute insults in late gestation cause neuronal death in the cortex and striatum, but 
less severe white matter damage (Loeliger et al., 2003). 
3. Chronic insults (placental insufficiency) results in growth restriction, reduced brain 
weight, enlarged lateral ventricles (Mallard et al., 1999), reduced basal ganglia volume 
(Rehn et al., 2004), and reduced axonal myelination in the CNS. 
To sum up, animal models provide extensive evidence for the propensity of OCs to 
induce brain morphological alterations and disturbances of dopamine metabolism as 
observed in schizophrenia patients. 
 
1.5 Neuroimaging  
The first in vivo neuroimaging studies of schizophrenia patients were 
pneumoencephalographic studies undertaken in the 1920ies. These studies produced 
the earliest reports on enlarged ventricles in schizophrenia patients as compared to 
healthy controls (Jacobi & Winkler, 1927;Keshavan et al., 2008). The use of computer 
tomography (CT) scans of the brain for research purposes started in the 1970ies 
(Shenton et al., 2001), but its use was limited by the harm accumulated amounts of x-
ray radiation impose on human tissue. This limitation did not apply to the magnetic 
resonance imaging (MRI) examinations introduced in clinical brain research in the 
1980ies. Furthermore, MRI was already then superior to CT in depicting brain 
anatomy, especially the differences of grey and white matter and the anatomy of the 
cerebellar fossa. 
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1.5.1 MRI  
MRI images of human tissue are measurements of an induced signal from hydrogen 
atoms (1H) (Weishaupt et al., 2006). Hydrogen atoms are widely distributed in all the 
body tissues. In the atom, the proton possesses positive charge and spin, and the 
proton rotates about its own axis. When a tissue is exposed to a static magnetic field, 
the spin of the hydrogen atoms within this tissue aligns with the direction of the 
magnetic field. By applying a radiofrequency pulse (RF) specific to hydrogen, the spin 
system gets excited, and some of the spins are tipped away from their original 
alignment. When the radiofrequency signal is removed, it induces an alternating 
voltage of the same frequency as the larmor frequency2 in a receiver coil: the MR 
signal. This MR signal fades rapidly due to reduction of the transverse magnetization 
by spin-lattice-interaction (T1-relaxation) and spin-spin interaction (T2-relaxation).  
Briefly, in T1-relaxation, the nuclei return to their ground state by dissipating their 
excess energy to the surroundings (the lattice). The time constant for this recovery is 
dependent on the strength of the external magnetic field and the internal motion of 
the molecules. On T1-weighted MRI scans, water (and CSF) appear dark. T2-
relaxation reflects loss of phase coherence3; the spins do not lose energy to the 
surroundings but rather exchange energy with each other. On T2-weighted MRI scans 
water (and CSF) appear bright. The signal intensity is sensitive to the biochemical 
properties of the tissues and depend on proton density (the number of excitable spins 
per unit volume), the T1 relaxation time constant (corresponds to the time before the 
excited spins in a given tissue are recovered and ready for new excitation), the T2 
relaxation time constant (determines how quickly a signal fades after excitation), flow 
and temperature (Agartz, 2008).  
The MRI signals are collected in the receiver coils as frequencies and temporarily 
stored in K-space. After the scanning is finished, the raw data stored in K-space is 
mathematically transformed (by Fourier transforms) in order to reconstruct the 
original image in spatial coordinates (McRobbie, 2007). With the currently used pulse 
sequences, the reconstructed MR-images have a resolution of approximately 1-2 mm3  
(Agartz, 2008). 
                                                 
2 The larmor frequency is given by the  larmor equation: ω0= γ0 · B0,  
where ω0 signify the larmor frequency in megahertz, γ0 signify the gyromagnetic ratio (a constant 
specific to a particular nucleus), and B0 signify the strength of the magnetic field in tesla. 
 
3 When spins precess synchronously directly after excitation they have a phase of 0º, they are in 
phase. Phase coherence is gradually lost as some spins advance and others fall behind their 
precessional paths. The individual magnetic vectors then cancel each other out instead of adding 
together and the MR signal is lost as the transverse magnetization gradually disappears 
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Different image processing methods are used to measure neuroanatomical brain 
structures (morphometry). With the region of interest (ROI) method, manually or 
automatically delineated volumes of pre-defined structures are analysed, whereas 
with the voxel based method (VBM) comparison of the volume of the gray and white 
matter between groups of interest can be performed for each voxel of the cerebral 
volume without the need to explicitly define regions of interest in advance. With 
surface based methods (SBM), cortical complexity can be analysed with great 
precision (Dale et al., 1999;Fischl et al., 1999a;Schaer et al., 2008). 
The structural MRI (sMRI) technique is used when examining neuroanatomy. Other 
MRI techniques include perfusion imaging, diffusion tensor imaging (DTI) studying 
connectivity, magnetic resonance spectroscopy (MRS) investigating neurochemistry, 
and functional MRI (fMRI) examining aspects of brain physiology (Gur et al., 2007). 
 
1.5.2 MRI in schizophrenia 
MRI is an invaluable tool for in vivo investigation of brain anatomy. Whereas post 
mortem examination of brain anatomy allows for description of cytoarchitecture 
(Benes, 1988;Bernstein et al., 2009;Selemon et al., 1998), in vivo MRI examination 
allows large scale case-control studies (Falkai et al., 2007;Goldman et al., 2009), 
longitudinal studies (Ho et al., 2003;van Haren et al., 2007), studies of first-episode 
cases (Steen et al., 2006) and high-risk samples (Job et al., 2003;Witthaus et al., 
2010), as well as childhood- and adolescent-onset schizophrenia studies (Gogtay, 
2008;Voets et al., 2008;White et al., 2003) with robust numbers of cases and controls. 
The larger subject samples facilitate the investigation of e.g. genetic- (Agartz et al., 
2006;van Haren et al., 2008), medication- (Smieskova et al., 2009), and cannabis use 
(Bhattacharyya et al., 2009) effects on brain structure. 
The earliest MRI studies on brain anatomy in schizophrenia revealed enlarged 
ventricles (Andreasen et al., 1990;Kelsoe, Jr. et al., 1988) in line with previous 
findings from CT studies (Johnstone et al., 1976;Weinberger et al., 1979), and were 
suggestive of reduced brain tissue (Ward et al., 1996). From MRI studies, smaller 
hippocampal volumes have consistently been reported in schizophrenia patients 
(Steen et al., 2006;Stefanis et al., 1999;Velakoulis et al., 2006;Wang et al., 2008). 
Studies on basal ganglia volumes display more heterogeneity in results (Ballmaier et 
al., 2008;Glenthoj et al., 2007;Mamah et al., 2007;Tamagaki et al., 2005), some of 
which may be attributed to the use of antipsychotic medication that acts upon 
dopamine receptors abundant in the basal ganglia (Scherk & Falkai, 2006;Smieskova 
et al., 2009). Cortical complexity has been an obstacle to the study of case-control 
differences in cortical folding and thickness. Prefrontal and temporal volume 
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reductions have been reported, using a region of interest approach (Suddath et al., 
1989;Yamasue et al., 2004;Breier et al., 1992) or voxel-based morphometry (Gur et 
al., 2000;Honea et al., 2005;Sanfilipo et al., 2000). Advances in MRI post processing 
tools have facilitated automated surface-based three dimensional analyses of the 
cortex. With these methods, e.g. widespread cortical thinning has been reported in 
schizophrenia patients (Kuperberg et al., 2003;Nesvag et al., 2008).  
Brain morphological alterations have been reported to be present in first-episode 
schizophrenia (Crespo-Facorro et al., 2009;Ebdrup et al., 2010;Kubicki et al., 
2002;Narr et al., 2005;Schultz et al., 2010;Witthaus et al., 2009), in subjects at high 
genetic risk (Job et al., 2003;Job et al., 2005;Lawrie et al., 2001;Lawrie et al., 2002) 
and in subjects with prodromal symptoms of schizophrenia (Witthaus et al., 
2010;Jung et al., 2009;Hurlemann et al., 2008;Borgwardt et al., 2007;Pantelis et al., 
2003). Also childhood onset schizophrenia (COS) (White et al., 2003) and adolescence 
onset schizophrenia (AOS) and psychosis (Douaud et al., 2007;Janssen et al., 
2009;Voets et al., 2008) patients also demonstrate brain morphological abnormalities 
compared with healthy control subjects. Heterogeneous findings have been reported 
from studies on case-control differences in cortical folding; schizophrenia patients 
demonstrate prefrontal hypergyria (higher GI)(Falkai et al., 2007;Harris et al., 
2007;Vogeley et al., 2001), lower prefrontal (Bonnici et al., 2007) and global (Cachia et 
al., 2008;Sallet et al., 2003) GI, increased metric distortion (an indirect measure of 
cortical displacement and convolution) in the left pars triangularis (Wisco et al., 2007), 
and no abnormalities (Highley et al., 2003) when compared to healthy controls. Taken 
together, the above findings points towards an early origin for the brain morphological 
abnormalities reported in schizophrenia patients. 
Progressive brain morphological abnormalities after illness onset (Ho et al., 2003;van 
Haren et al., 2007) and around transition to psychosis (Takahashi et al., 2009) have 
been reported in longitudinal studies, but negative findings have also been reported 
(Whitworth et al., 2005). In addition, typical antipsychotic medication has been 
related to reduced cortical volumes and increased basal ganglia volumes, whereas a 
change to atypical antipsychotics may reverse the basal ganglia enlargement (Scherk 
& Falkai, 2006;Smieskova et al., 2009). As a consequence, brain abnormalities of 
putative early neurodevelopmental origin may be confounded.  
 
1.5.3 MRI and obstetric complications in schizophrenia  
Enlarged ventricles have been reported to be larger in schizophrenia patients with 
than without a history of OCs. In monozygotic twins discordant for schizophrenia, 
enlarged lateral ventricles in the ill twin were associated with prolonged birth (McNeil 
22 
 
et al., 2000). Neonatal OCs has been associated with larger ventricles in schizophrenia 
patients (Falkai et al., 2003). However, two CT studies from the 1990ies did not find 
an association between OCs and ventricle volume (Reddy et al., 1990;Smith et al., 
1998).  
Increased ventricle to brain ratio (VBR) is suggestive of volume reductions in grey 
and/or white matter tissue. The smaller hippocampal volume in schizophrenia has 
been reported to be even smaller in schizophrenia patients with than without a history 
of OCs (Ebner et al., 2008;McNeil et al., 2000;Schulze et al., 2003;Stefanis et al., 
1999;van Erp et al., 2002). Schizophrenia patients with OCs (but no family history of 
schizophrenia) have been reported to have smaller hippocampal volumes when 
compared to patients with a family history of schizophrenia (but no OCs), a finding 
that suggests OCs to be of greater importance than heritability risk to the reduced 
hippocampal volumes in schizophrenia (Stefanis et al., 1999). Bilateral hippocampal 
reductions related to OCs have been reported in schizophrenia patients and their 
siblings (Ebner et al., 2008), and left hemisphere hippocampal reductions related to 
OCs have been reported in schizophrenia patients and in their relatives, at a trend 
level (Schulze et al., 2003). Empirical evidence for an interaction effect between 
heritability risk and foetal hypoxia on hippocampal volume has been put forward (van 
Erp et al 2002); schizophrenia patients tended to demonstrate smaller hippocampi if 
subjected to foetal hypoxia whereas their siblings and healthy controls did not, these 
group differences not reaching statistical significance. The findings suggest that 
genetic liability for schizophrenia may modulate the effect of OCs on hippocampal 
volume. 
Reduced cortical prefrontal and temporal volume has been reported in schizophrenia 
patients subjected to prenatal hypoxia (Cannon et al., 2002b). Cortical volume is the 
product of cortical thickness and cortical area (Voets et al., 2008), perhaps also 
related to cortical folding. Whereas one study of the association between OCs and 
cortical folding in schizophrenia yielded negative results (Falkai et al., 2007), no 
studies on the association between OCs and cortical thickness or area have been 
conducted. It is therefore not as yet possible to conclude whether reduced cortical 
thickness, -area, or both underpin the volume reductions observed.   
In non-clinical samples, severe OCs such as prematurity and intra-uterine growth 
restriction have been related to brain morphological abnormalities. Cortical thickness 
reductions have been demonstrated in adolescents with very low birth weight 
(Martinussen et al., 2005) and cortical volume reductions in premature children 
(Soria-Pastor et al., 2009). Studies of gyrification in premature (compared to term) 
infants have demonstrated altered temporal gyrification bilaterally (Kesler et al., 
2006), and higher sulcation index (a measure of cortical folding), when related to 
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brain surface, in preterm intra-uterine growth restriction infants (compared with 
“normal” preterm) infants (Dubois et al., 2008). Thus, adverse pre- and perinatal 
events have the propensity to cause morphological alterations that may be detectable 
in the brain several years after birth. Since cortical folding patterns develop in utero, 
and stay by and large stable postnatally (Armstrong et al., 1995), they may be a valid 
”window” to study effects of harmful pre- and perinatal events such as OCs. 
 
1.6 Schizophrenia susceptibility genes 
Heritability estimates in schizophrenia have been reported to be as high as 80% 
(Sullivan et al., 2003); the concordance rates of monozygotic and dizygotic twins have 
been reported to be 40% and 5% respectively (Cardno et al., 1999). The heritability of 
schizophrenia follows a complex trait; the genetics underpinning the schizophrenia 
phenotype do not follow classic Mendelian dominant or recessive single locus 
properties (Kendler & Eaves, 2005). Complex traits result from effects of multiple 
genetic and environmental influences, where each gene only confers a relatively small 
risk effect. The genes have low penetrance and relatively high allele frequency in the 
population. Environmental risk factors are important in complex traits i.e. gene-
environment interactions are common (Waldman, 2003). Models for the genetic effect 
in schizophrenia include the “common illness-common allele” model, where the illness 
is caused by a combination of modest effects of variation in several alleles, and the 
“multiple highly penetrant gene variations” model, where individually rare mutations 
e.g. genetic microdeletions or microduplications (copy number variations) occur rarely 
but have high penetrance (Prasad & Keshavan, 2008;Walsh et al., 2008). 
Over the last years, evidence for several genetic associations to schizophrenia risk has 
been put forward (Harrison & Weinberger, 2005). From linkage studies4, DISC1 
emerged as a schizophrenia susceptibility gene (Millar et al., 2000). From association 
studies5, genes involved in neuronal migration (e.g. DISC1 (Saetre et al., 2008;Zhang 
et al., 2006) and reelin (Liu et al., 2010;Shifman et al., 2008)), dopamine metabolism 
(e.g. COMT (Chen et al., 2004;Wonodi et al., 2003)), and neurodevelopment (BDNF, 
NRG1, DTNBP1, GRM3) (Arnold & Rioux, 2001;Harrison & Weinberger, 2005;Harrison 
et al., 2008;Numakawa et al., 2004;Webster et al., 2006) have been associated with 
schizophrenia susceptibility. Of particular relevance to the neurodevelopmental 
hypothesis of schizophrenia, a high proportion of schizophrenia susceptibility genes 
are involved in prenatal neurodevelopment and regulated by hypoxia-ischemia 
                                                 
4 In linkage studies, large pedigree samples are analyzed to discover chromosomal regions where 
genes involved in the illness are likely to be found (Lang et al., 2007)  
5 In association studies, single nucleotide polymorphism (SNP) variation in genes putatively involved 
in schizophrenia (e.g. after discoveries in linkage studies) are investigated 
24 
 
(Schmidt-Kastner et al., 2006). To date, one study has suggested an interaction effect 
between severe OCs and SNP variation in seven SNPs from four schizophrenia 
susceptibility genes (AKT1, BDNF, DTNBP1, and GRM3) regulated by hypoxia on 
schizophrenia risk (Nicodemus et al., 2008).  
Molecular markers of schizophrenia susceptibility have been associated with brain 
structural alterations in schizophrenia. Some of the genes are related to 
neurodevelopment; SNP variation in BDNF has been associated with volumes of 
occipital, temporal, and parietal lobe volumes (Ho et al., 2006), and frontal grey 
matter and caudate volume (Agartz et al., 2006). Among schizophrenia patients and 
healthy controls, carriers of the DISC1 leu607phe polymorphism phe-allele have 
smaller prefrontal grey volumes (Szeszko et al., 2008). Ventricle enlargement has been 
associated with allele variation in the reelin gene (Gregorio et al., 2009) and NRG1 
(Mata et al., 2009), smaller hippocampal volumes with NRG1 allele variation (Gruber 
et al., 2008), and altered prefrontal volumes with variation in AKT1 (Tan et al., 2008).  
However, if SNP variation in genes of relevance to schizophrenia susceptibility and 
neuorodevelopment interact with OCs in their effect on brain morphology, has 
previously not been investigated. 
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2. Aims 
The main aim of this PhD thesis was to investigate the effects of a history of obstetric 
complications (OCs) on brain morphology in patients with schizophrenia. The sub 
aims were to determine if such putative effects could explain some of the differences 
in brain morphology between schizophrenia patients and healthy controls, and to 
investigate if the effects of OCs on brain morphology are modified by genetic variation 
(allele variation in single nucleotide polymorphisms).  
The theoretical framework for the current aims is the neurodevelopmental hypothesis 
of schizophrenia, and the empirical foundations for these aims are derived from three 
areas of research;  
1) epidemiological studies of OCs as risk factors to develop schizophrenia,  
2) animal models that demonstrate brain morphological alterations as a result of pre- 
and perinatal adversities alone and in interaction with genetic variation,  and 
3) neuroimaging studies that show abnormalities of brain morphology in 
schizophrenia patients as compared to healthy controls,  
The following research questions and hypotheses were explored and tested in the four 
studies included in the thesis. The studies address either hypotheses that have 
previously not been investigated (study I, II, and IV) or they apply new methods to 
previously tested hypotheses (study III). 
 
Study  I 
How do OCs relate to the volume of basal ganglia nuclei known to be of importance to 
schizophrenia pathology?  
Based on the fact that dopamine metabolism is altered in schizophrenia and 
vulnerable to OCs, we hypothesized that increased number and severity of OCs would 
be related to the volume of the dopamine fibre rich basal ganglia (nucleus accumbens, 
nucleus caudatus, globus pallidum, and putamen) in schizophrenia patients but not 
in healthy controls.  
 
Study  II 
Do patients with history of OCs and/or foetal hypoxia have thinner brain cortices? Is 
this found also in healthy control subjects? 
Cortical thickness differs in schizophrenia patients versus healthy controls. As OCs 
affect cortical morphology in animal models, we hypothesized that that higher number 
and/or severity of OCs and/or foetal hypoxia would be significantly associated with 
thinner brain cortices, and that this association would be different between 
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schizophrenia patients and healthy controls, with greater thinning (general or 
regionally specific) in patients. 
 
Study III 
Is increased number and severity of OCs associated with altered cortical folding in 
schizophrenia? Will applying a surface-based three-dimensional method to calculate the 
gyrification index detect subtle deviances in cortical folding related to OCs? 
Cortical folding occurs prenatally and remains by and large stable postnatally. 
Differences in cortical folding patterns between schizophrenia patients and healthy 
controls may reflect aberrant pre-natal neurodevelopment in schizophrenia. The 
cortex is a complex three dimensional (3D) structure, and by using the two 
dimensional (2D) gyrification index, information related to buried sulci and sublobar 
structures may be lost. We hypothesized (1) that OCs would be related to cortical 
folding as measured by a 3D surface-based local gyrification index, (2) that this 
relationship would be different in schizophrenia patients and healthy control subjects. 
 
Study  IV 
Does variation in hypoxia-regulated schizophrenia susceptibility genes modulate the 
effect of OCs on hippocampal volume? 
As hypoxia is a core feature of OCs and a strong modifier of gene expression, we 
hypothesized that the effect of OCs on hippocampal volume could be modified by 
variation in hypoxia-regulated genes. Consequently, we explored if 1) there was a 
statistically significant relation between a history of hypoxia-related severe OCs and 
hippocampal volume, and 2) if such a putative relationship was modulated by allele 
variation in four genes that are regulated by hypoxia and associated with 
schizophrenia (NRG1, BDNF, GRM3 and DTNBP1).  
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3. Methods 
3.1 Subject sample 
The four studies in this thesis are conducted on the same subject sample. The subject 
sample was part of the Human Brain Informatics Project (HUBIN) at the Karolinska 
Institutet, Stockholm, Sweden. HUBIN is a comprehensive database of genetic, brain 
morphological, neuropsychological, and clinical information obtained from 
schizophrenia patients and healthy subjects. The inclusion of subjects who 
participated in the current study took place between 1999 and 2003. All participants 
gave written informed consent. The project was approved by the Research Ethics 
Committee at Karolinska Institutet and the Swedish Data Inspection Board 
(“Datainspektionen”). The study was performed in accordance with the Helsinki 
Declaration. 
The subject sample consisted of unrelated Caucasian men and women currently 
resident in the Stockholm Area. Except from one subject born in Finland, all subjects 
were born in Sweden between the years 1943 and 1982. Demographic and clinical 
data are listed in Table 1. 
 
Table 1. Demographic and clinical characteristics in schizophrenia patients and 
healthy control subjects. 
 Patients (n=54) Controls (n=54) Statistics 
 Mean S.E. Mean S.E. Test-value p-value 
Age at MRI (years) 41.9 1.1 41.5 1.2 t=.28 ns 
Age at illness onset 
n=53 (years)  
24.9 0.8 na   na 
Duration of illness 
(years) 
16.8 1.3 na   na 
 Number % Number %   
Gender (male/female) 37/17 68/32 33/21 61/39 

2=.65 ns 
Handedness n=105 
(right/left/ambidextr.)  
48/2/2 92/4/4 48/3/2 91/6/4 

2=.19 ns 
Medication 
(typical/atypical/none) 
25/26/3 46/48/6 na   na 
 
 
3.1.1 Patients 
Invited patients from the out-patients clinic underwent a comprehensive clinical 
assessment protocol using validated operational instruments (Ekholm et al., 
2005;Vares et al., 2006) including symptom severity scores by SANS/SAPS 
(Andreasen, 1983;Andreasen, 1984). Handedness was ascertained by means of asking 
the patients which hand they preferred when writing, using scissors, and 
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throwing/catching a ball. Verification of psychiatric diagnosis was performed by a 
trained psychiatrist by the use of structured clinical interviews (SCID (Spitzer et al., 
1988) and OPCRIT (McGuffin et al., 1991)). Patients fulfilled DSM-III-R and DSM-IV 
criteria for schizophrenia (n=50) or schizoaffective disorder (n=4). The mean duration 
of illness was 16.8 years (range 0.4-41.1 years), and mean age of illness onset was 
24.9  years (range 15.9-39.5 years).   
The antipsychotic medications used by patients in the present study documented at 
the time of MRI were as follows: typical antipsychotic medication (n=25) included 
Perphenazine (n=9), Zuclopenthixole (n=5), Haloperidol (n=10), and Flupenthixole 
(n=1); atypical antipsychotic medication (n=26) included Risperidone (n=8), Clozapine 
(n=9), and Olanzapine (n=9). Two subjects had both typical and atypical antipsychotic 
medication and three patients had no medication at the time of MRI. 
 
3.1.2 Control subjects 
Control subjects were recruited using three different approaches. The first group 
(n=25) had previously (2–19 years earlier) served as healthy comparison subjects in 
biological psychiatric research at the Karolinska Institutet (Damberg et al., 2004). 
They were reassessed for lifetime psychiatric diagnosis (Jonsson et al., 2000). A 
second group of controls (n=14) was recruited from hospital staff or their relatives for 
the present study. A third control group (n=15) was recruited from a population 
register for the present study. This combined recruitment strategy was used due to 
the high dropout rates, sometimes approaching 95% (Oxenstierna et al., 1996), when 
subjects are recruited from the general population for demanding biological 
psychiatric research. The control subjects were interviewed by a trained psychiatrist 
and they were found to have no previous or current psychiatric disorders according to 
a semi-structured diagnostic interview (SCID-non-patient version (Spitzer et al., 
1986)). They were matched to the patients by age and gender (on a group level). The 
blood sample collected from one control subject was insufficient for proper genotyping; 
53 control subjects were thus included in study IV. 
 
3.1.3 Exclusion criteria 
Exclusion criteria for all subjects were a history of head trauma with loss of 
consciousness >5 minutes, current treatment for substance abuse, and/or somatic 
disorders affecting brain function.  
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3.2 MRI scan aquisition 
MR images were obtained at the MR Research Centre at Karolinska Institutet, 
Stockholm, Sweden, using a 1.5 Tesla GE signa Echo-speed (Milwaukee, Wis., USA) 
scanner. T1-weighted images were obtained using a three-dimensional spoiled 
gradient recalled (SPGR) pulse sequence with the following parameters; 1.5 mm 
coronal slices, no gap, 35° flip angle, repetition time (TR) = 24 ms, echo time (TE) = 6.0 
ms, number of excitations (NEX) = 2, field of view (FOV) = 24 cm, acquisition 
matrix = 256 × 192. T2-weighted images were acquired with the following parameters; 
2.0 mm coronal slices, no gap, TR = 6,000 ms, TE = 84 ms, NEX = 2, FOV = 24 cm, 
acquisition matrix = 256 × 192. All scans included were visually judged to be without 
obvious motion artefacts. A trained neuroradiologist evaluated all scans to be without 
gross pathology.   
 
3.3 MRI post processing 
MRI post processing by automated software tools was used in all studies. The soft 
ware suite FreeSurfer was used in all studies and the BRAINS program was used in 
parts of studies I and IV. In addition, manual delineations of hippocampal volumes 
were used in  
study IV. 
 
3.3.1 FreeSurfer 
3.3.1.1 Cortical thickness 
The Free-Surfer v.1.2 software package (http://surfer.nmr.mgh.harvard.edu) was 
used to obtain estimates of cortical thickness (in study II). Cortical thickness was 
measured by reconstructing representations of the grey/white matter boundary and 
the cortical surface on T1 weighted images (see Figure 2), and then calculating the 
distance between those surfaces at each point (vertex) across the whole cortical 
mantle, a total of approximately 162,000 vertices in each hemisphere (Dale et al., 
1999). Topological defects in the grey/white matter boundary were routinely manually 
corrected by laboratory technicians, under direct supervision of senior researchers, 
blind to subject identity. The resulting cortical thickness maps were averaged across 
participants using a non-rigid high-dimensional spherical averaging method to align 
cortical folding patterns (Fischl et al., 1999b). This procedure results in a mean 
measure of cortical thickness for each group at each point on the reconstructed 
surface (Fischl et al., 1999a;Dale et al., 1999). This method has been validated by 
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histological  (Rosas et al., 2002) as well as manual measurements (Kuperberg et al., 
2003). 
 
Figure 2. Cortical reconstruction with the FreeSurfer method demonstrated in horizontal, coronal, 
and sagittal views. The green line represents the border between grey and white matter, the red line 
represents the pial surface, and the yellow line the outer surface (courtesy by Marie Schaer, (Schaer 
et al., 2009)).  
 
 
 
Figure 3. Subcortical segmentation with FreeSurfer, coronal view. CA= nucleus caudatus, PA= 
globus pallidum, PU= putamen, HI= hippocampus (hippocampal formation). Nucleus accumbens is 
localized anterior to nucleus caudatus and is not included in this MRI slice (image by Petr S. 
Bjerkan and Anders Haukvik).  
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3.3.1.2 Basal ganglia volumes and the hippocampal formation 
In studies I and IV, MRI post processing was performed using FreeSurfer version 
3.0.2. (http://surfer.nmr.mgh.harvard.edu). Automated measurements of total 
volumes of putamen, globus pallidum, nucleus accumbens, nucleus caudatus, and 
the hippocampal formation (hippocampus) were obtained from the T1-weighted images 
(see figure 3). The automated segmentation algorithm combines information on image 
intensity, probabilistic atlas location, and the local spatial relationships between 
structures to automatically assign a neuroanatomical label to each voxel in the MRI 
volume (Fischl et al., 2002). The software does not classify the grey and white matter 
fractions of the total volumes. The reliability of the automatic volume measurements 
using FreeSurfer has been tested against manual tracings, and the agreement 
between the automated FreeSurfer volumes and manual volume measures has been 
reported to be comparable to that obtained by comparing the manual volume 
measures of different experts (Fischl et al., 2002). The subcortical segmentation has 
been reported to be stable across averaging of multiple acquisitions, acquisition 
sequences, major scanner upgrades and segmentation atlas within the same scanner 
(Jovicich et al., 2009). The hippocampal segmentation include the fimbria and 
represent the hippocampal formation (Makris et al., 1999). 
 
3.3.1.3 Gyrification index 
In study III, first, cortical reconstructions were obtained from T1-weighted images 
using the automated computer software FreeSurfer version 3.0.2. Second, we used the 
lGI algorithm (http://surfer.nmr.mgh.harvard.edu/fswiki/LGI) to compute 
measurements of local gyrification at thousands of vertices across the cortical mantle. 
From the vertex-wise lGI measurements, the average local gyrification index was 
calculated for 34 pre-defined anatomical cortex parcellations (Desikan et al., 2006) in 
each hemisphere. The lGI method is adapted from the classical gyrification index (2D-
GI), which is the ratio of the total pial cortical surface over the perimeter of the brain 
delineated on coronal sections. The lGI method iteratively quantifies GI in circular 
three-dimensional regions of interest. After the creation of an outer envelope that 
tightly wraps the pial cortical surface, local measurement of circular GI is computed 
for each vertex of the outer surface as the ratio of corresponding regions of interest 
(ROI) on the hull and pial meshes is created. Delineation of the ROI on both the outer 
surface (ROIO) and pial surface (ROIP) uses a matching algorithm based on geodesic 
constraints, so that the ROIP takes into account the entire patch of the cortical 
surface delineated by the ROIO circular perimeter (see figure 4). At the end of the 
computational process, individual lGI cortical maps reflect the amount of cortex 
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buried within the sulcal folds in the surrounding circular region. The method has 
been described and validated (Schaer et al., 2008). 
 
 
Figure 4. Cortical reconstruction and lGI-computation with the FreeSurfer method. The circular 
region of interest on the outer surface (ROIO) is marked in yellow, and the corresponding region of 
interest on the pial surface (ROIP)  is marked in red, see text in 3.3.1.3 for details (courtesy by Marie 
Schaer (Schaer et al., 2009)). 
  
 
 
 
3.3.2  BRAINS 
Brain tissue segmentation was also performed using the software suite BRAINS 
(Andreasen et al., 1993) from both T1- and T2-weighted MRI scans re-sliced to 1-mm3 
voxels in standardized space. Using an automatic tissue classification procedure all 
brain tissue was classified in the following tissue class volumes: grey matter, white 
matter, CSF, and venous blood (Agartz et al., 2001;Harris et al., 1999). In the present 
studies I and IV, measurements of intracranial volume (ICV) obtained using BRAINS 
were used to correct for inter-individual differences in head size. In addition, in study 
I measures of nucleus accumbens, nucleus caudatus, and putamen, available for 60 
subjects (patients and controls), as obtained automatically (nucleus caudatus and 
putamen) or by manual delineations (nucleus accumbens), were used to test the 
reliability of the FreeSurfer measures of the same structures. In study IV, manual 
delineations of the hippocampus available for 60 subjects were used for a re-analysis, 
as the main analysis in this study gave unexpected results. The inter-rater reliability, 
measured by intra class correlation (ICC) for the striatal structures was 0.93 for total 
striatum, 0.96 for caudate, 0.85 for putamen, and 0.79 for nucleus accumbens 
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(Agartz et al., 2006). For the hippocampus intra-rater reliability (ICC) was >0.98 for 
both hemispheres hippocampi (unpublished data). 
 
3.3.3 Correlation between methods 
The correlation between the combined left and right hemisphere volume measures of 
the basal ganglia from FreeSurfer and BRAINS was r=0.56 (p<0.0005) for nucleus 
accumbens, r=0.86 (p<0.0005) for nucleus caudatus, and r=0.85 (p<0.0005) for 
putamen. The correlation between hippocampal measures from FreeSurfer (including 
the white matter of the fimbria and the alveus) and the grey matter fraction of the 
hippocampus as manually delineated within the BRAINS program was r=0.52 
(p<0.001).  
 
3.4 Assessment of obstetric complications 
In the studies included in this thesis, OCs were defined in accordance with previous 
research (McNeil & Cantor-Graae, 1999) as ‘‘...the broad class of somatic deviations 
from an expected, normal course of events and offspring development during 
pregnancy, labour-delivery, and the early neonatal period”. Information on OCs was 
collected from hospital birth records. Obstetric care in Sweden has been of high 
quality all this period, and the birth records were very detailed. The information was 
scored according to the McNeil-Sjöström Scale For Obstetric Complications (McNeil & 
Sjostrom, 1995) by a physician (UKH) who was blinded to patient/control status and 
MRI-results. Sixty-two birth records had previously been scored by another physician 
(MD, PhD), and the intra-class correlation between the two raters (for all 62 records) 
was 0.93. The McNeil-Sjöström scale rates OCs for severity of probable harmful effect 
on the offspring  according to severity at an ordinal scale from 1-6, where severity 
level one signifies a “not harmful or relevant” event and 6 signifies “very great harm to 
or deviation in offspring”.  The McNeil-Sjöström scale is organized according to the 
following major sub-categories: 
I.  Pregnancy complications 
a) foetal/foeto-placental conditions, b) maternal disorders, c) medical examinations 
and interventions, d) maternal toxins/radiation, e) maternal legal medication, f) 
maternal illicit drugs and other stimulants, g) other maternal trauma 
II.  Labour-delivery complications 
III. Neonatal complications 
a) deviations in gestational age/weight/maturation, b) congenital structural 
malformations c) neoplasm, d) congenital infections, e)  neonatal disorders, f) 
34 
 
treatment including offspring medications, g) breast feeding associated with maternal 
illness, medications and substance abuse. 
The scale also divides scores for the given reproduction in total into scores for the 
specific pregnancy trimesters, total pregnancy, labour-delivery, neonatal period and 
total reproduction. The scale has been constructed for the use in clinical case-control 
studies in which individual complications (e.g. low birth-weight, prematurity, or 
placental abruption) occur too infrequently to be assessed separately (McNeil et al., 
1994).  
In study I and III, the number of OCs with severity scores of 3 and above was 
calculated for each individual subject to form one continuous variable. Scores under 3 
are considered to be not harmful to the foetus and were therefore not included in the 
analyses; individuals with “complications” of grade 1 or 2 were classified as having 
had no complications (and grouped with all individuals with no reported 
complications).  
In study II, analyses were undertaken using the OC scores in different ways. For one 
analysis the number of OCs with severity level 3 or above was calculated for each 
subject to form a continuous variable as described above. In the other analyses, the 
subject sample was divided into groups comprising subjects above or below a set cut-
off for OCs. The cut-off level was one or more complications of severity 3 for total 
pregnancy and trimester scores, and one or more complications of level 4 for labour-
delivery scores. For the composite OC-score (Total OCs) the cut-off level was two 
complications of severity level 4 and above. Furthermore, the cut-off for severe OCs 
was one or more complications of severity level 5 or 6. A complication of severity level 
5 is defined as a complication that is ‘‘potentially clearly greatly relevant/harmful” 
(e.g. severe preeclampsia or foetal asphyxia), and a complication of level 6 is defined 
as a complication that causes ‘‘very great harm to or deviation in offspring” (e.g. 
eclampsia, offspring hypoxic-ischemic cerebral injury). Finally, to increase 
comparability to previous studies, a foetal hypoxia variable was constructed according 
to Cannon et al (2002b) was estimated. Foetal hypoxia was considered present if 
asphyxia was recorded or if the infant was coded blue at birth, or if two or more of the 
following occurred: umbilical cord knotted or wrapped tightly around the neck at least 
once, placental infarcts, third-trimester bleeding, preeclampsia, maternal anaemia, 
maternal anorexia, foetal heart rate deviations, breech presentation, or premature 
birth (<week 37).  
In study IV, the severe OCs cut-off variable as described under study 2 were utilized 
alone. Severe OCs were present in 28 of the total 108 subjects, including 15 of the 
patients and 13 of the controls. Most subjects with severe OCs (25/28) had severity 5 
OCs, the remaining 3 subjects with a complication of grade 6 all being born before 
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gestational week 33. The recorded severe OCs were as follows: Prolonged birth (13 
subjects), meconium-stained amniotic fluid (5 subjects), asphyxia (3 subjects), 
prematurity < 32 weeks (3 subjects), placental abruption (2 subjects), bleeding during 
first trimester (2 subjects), meconium aspiration syndrome (2 subjects), prematurity < 
35 weeks (2 subjects), twin transfusion syndrome (1 subjects), mid-forceps delivery (1 
subject), small for gestational age (1 subject), acute caesarean section (1 subject), and 
low birth weight (1 subject). 17 subjects were exposed to one severe OC, and the 
maximum number was five complications in one subject. The number of subjects with 
OCs as described above are listed in Table 2. 
 
 
Table 2. Obstetric variables and complications in the current subject sample 
 Patients (n=54) Controls (n=54) p-values 
 Mean (SD) Range Mean (SD) Range  
Birth weight (g) 3494 (635) 1770-5630 3397 (665) 1460-4720 0.44 
Head circumference (cm) 
n=105 
33.8 (1.5) 30-37 33.7 (1.6) 28-36 0.77 
Maternal age (years) 27.5 (5.6) 17-43 27.9 (5.6) 18-39 0.72 
Gestational age (weeks) 39.2 (1.9) 32-42 39.4 (2.2) 31-43 0.52 
Continuous OCs score 6.0 (5.3) 0-28 5.5 (4.6) 0-23 0.53 
 Number  % Number  %  
Total OCs 21  39 26  48 0.33 
1. trimester 6  11 6  11 1 
2. trimester 11  20 10 19 0.81 
3. trimester 24  44 21  39 0.56 
Total pregnancy 25  46 21  39 0.44 
Labour-delivery 28  52 24  44 0.70 
Severe OCs 15  28 13  24 0.66 
Hypoxia 12 22 7 13 0.21 
  
 
3.5 Genotyping 
For study IV, 32 schizophrenia-related single nucleotide polymorphisms (SNPs), 
located in four hypoxia-regulated genes, were selected for genotyping. The SNPs were 
genotyped as part of the Scandinavian Collaboration on Psychosis Etiology (SCOPE) 
project, a Scandinavian collaborative study on the genetics of psychotic disorders. The 
SNPs were selected on the basis of previous positive findings from other research 
groups and independent hypotheses on genes involved in psychosis, 
neurodevelopmental pathways or CNS function. Genomic DNA was extracted from 
whole blood samples, and SNPs located in DTNBP1 (11 SNPs), GRM3 (5 SNPs), and 
NRG1 (12 SNPs) genes were genotyped at the SNP Technology Platform at Uppsala 
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University and Uppsala University Hospital, Sweden (www.genotyping.se), using the 
Illumina BeadStation 500GX and the 1536-plex Illumina Golden Gate assay (Illumina 
Inc., San Diego, CA, USA) (Jonsson et al., 2009). The four SNPs in the BDNF gene 
were genotyped by pyrosequencing (Ahmadian et al., 2000) or cleavage with restriction 
enzymes (Jonsson et al., 2006). The sample success rate was on average 99.8% for the 
genotyped SNPs. Hardy–Weinberg (HW) equilibrium was tested in affected and 
controls using Fisher’s exact test as implemented in PEDSTATS (Wigginton & 
Abecasis, 2005). 
 
3.6 Statistical analyses 
The statistical analyses in the four current studies were performed by the use of three 
different statistical software tools.  
1. SPSS version 16.0 (SPSS Inc, Chicago IL), all demographics, study I, and the 
analysis of the anatomical cortical parcels in study III 
2. Statistical functions within the FreeSurfer program 
(http://surfer.nmr.mgh.harvard. edu), study II and the vertex wise analysis in study 
III. 
3. SAS software (SAS/STAT® software, version 9.1.3, SAS institute Inc., Cary, NC), 
study IV. 
Statistical differences in demographic and obstetric variables between patient and 
control groups were evaluated using Chi-Square tests, independent sample Student’s 
T-tests and Mann–Whitney non-parametric tests.  
Multiple linear regression analyses were used to test the effect of OCs on basal ganglia 
volumes (study I), local gyrification in 68 anatomical cortical parcels (study III), and 
corresponding case control differences. The structure (or cortical parcel) was the 
dependent variable. Age, ICV, diagnosis, and OCs were the independent variables for 
the basal ganglia analyses; sex was excluded from these analyses due to confounding 
with ICV. Age, sex, diagnosis, and OCs were the independent variables for the 
gyrification analyses,. Model fit was assessed by analysing residuals and cook 
distances. 
A general linear model  (GLM) was used to test the effect of OCs on each vertex of the 
cortical mantle (study II), vertex wise local gyrification (study III), and hippocampus 
(including the gene-OCs interaction) (study IV). In study II, separate analyses for 
patients and controls for each obstetric variable were conducted, with a DODS 
(different onset, different slope) model contrast in patients or controls with OCs to 
patients without OCs  respectively. For the continuous OCs variable, separate DOSS 
(different onset same slope) analyses were conducted in patients and controls. The 
DODS analyses included cortical thickness as the dependent variable, various 
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dichotomous OCs scores as fixed factors, and age as a covariate. In the DOSS 
analysis, cortical thickness was the dependent variable, a continuous OCs measure 
the predictor variable, and age was co-varied for. In study III analyses of the vertex 
wise association between OCs and local gyrification were conducted in patients and 
control separately and in the combined group, with age and sex as covariates.  
A mixed linear model was used in study IV. In a first preliminary analysis on the 
hippocampal volume of the left and right hemisphere without SNP markers, diagnosis, 
severe OCs, the interaction between diagnosis and OCs, intracranial volume, age at 
MR scanning, and hemisphere side were treated as fixed factors, whereas individual 
was treated as a random factor. To test whether the effects of fixed factors differed 
between hemispheres, all interactions with hemisphere were included in the original 
model. Since the disease effect did not vary with presence/absence of severe OCs, the 
interaction between diagnosis and OCs was excluded from the statistical model. Since 
the effects of diagnosis, OCs, intracranial volume, and age at MR scanning on 
hippocampal volume did not differ significantly between the right and left 
hemispheres, the analyses were carried out on the average of left and right 
hemisphere hippocampal volumes. A linear model was used to carry out single marker 
allele association of the hippocampal volume including the number of minor alleles 
and excluding hemisphere in the above model for each SNP separately.  A mixed linear 
model was used to test whether the effects of diagnosis, OCs, and the interaction 
between OCs and RS13242038 on HCV depended on method of delineation 
(manual/automatic). In these analyses diagnosis, OCs, intracranial volume, age at 
MRI, number of minor alleles of RS13242038, and delineation method were 
considered as fixed factors, and individual as a random factor. To account for 
differences in reliability of methods, a separate residual variance was used for 
manually and automated HCV measurements, respectively. 
 
Multiple comparison control was performed with three different methods according to 
the nature of the statistical analysis performed. The Bonferroni method was applied in 
study I and the analysis of cortical anatomical parcels in study III. The Bonferroni 
corrected significance threshold  is found by dividing the α-level (in the current 
studies 0.05) by the number of tests performed (n), α/n. The false discovery rate (FDR) 
was used to control for multiple tests (>160.000 tests in each hemisphere) in study II 
and the vertex-wise part of study III. Finally, for the interaction effect of 32 SNPs and 
OCs on hippocampal volume (study IV), multiple comparison control was done by 
randomly permuting genotype among individuals 1000 times and re-analyzing the 
permuted data (Westfall and Young 1993). Thus genotypes and phenotypes were 
decoupled keeping the original LD structure of the genetic markers and the covariance 
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structure of phenotypes intact in each permuted data set. The adjusted p-value was 
defined as the fraction of permutations where the minimum p-value from allele 
associations, (or from its interaction with severe OC), was less than, or equal to, the 
minimum p-value in the original data. 
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4. Summary of studies 
 
Initial analyses showed that 1) there was equal distribution of number or severity of 
OCs in the patients and the controls, and 2) the full range of OCs from 3 or lower to 6 
was present in both groups. 
 
Study 1 
“No effect of obstetric complications on basal ganglia volume in schizophrenia” 
Based on the fact that dopamine metabolism is both a core feature in schizophrenia 
and vulnerable to OCs, we hypothesized that number and severity of OCs would be 
related to basal ganglia volume in schizophrenia patients but not in healthy controls. 
We thus analyzed and compared the effect of OCs on the volume of four basal ganglia 
structures (nucleus accumbens, nucleus caudatus, globus pallidum, and putamen) in 
patients with schizophrenia and healthy control subjects. 
A linear regression model was applied to study 1) case control differences in basal 
ganglia volumes (co-varying for intracranial volumes and age), 2) medication effects of 
typical vs. atypical vs. no use within the patient group (co-varying for age and ICV), 
and 3) the association between OCs and each of the basal ganglia volumes (co-varying 
for age, ICV, and case-control status). For reasons of validity, the basal ganglia 
volume measurements obtained by FreeSurfer were compared to volume measures 
previously obtained by a different software (BRAINS) or manually delineated. 
Patients demonstrated larger globus pallidum volumes than control subjects 
(p<0.0005), while caudate- (p=0.18), putamen- (p=0.49), and accumbens (p=0.20) 
volumes did not differ between patients and controls. No statistically significant effects 
of anti-psychotic medication given at the time of MRI on any of the four measured 
basal ganglia volumes were found. OCs were not significantly related to any of the 
basal ganglia structures after proper correction for multiple comparisons, but 
uncorrected results demonstrated a positive relationship between number and 
severity of OCs and nucleus accumbens volume (p=0.034) independent of diagnostic 
group. Also, no interaction effects of diagnosis and OCs were demonstrated.  
In conclusion, the results did not support the hypothesis. With the current severity of 
OCs, basal ganglia tissue volumes as studied by MRI appear unaffected by a history of 
OCs regardless if subjects have schizophrenia or not.  
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Study 2 
“Cerebral cortical thickness and a history of obstetric complications in 
schizophrenia” 
Cortical thickness differs in schizophrenia patients and healthy controls. As OCs 
affect cortical morphology in animal models, we hypothesized that that number 
and/or severity of OCs and/or foetal hypoxia would be significantly associated with 
thinner brain cortices, and that this association would differ between schizophrenia 
patients and healthy controls. 
A general linear model was used to study the effect of nine different measures on OCs 
and foetal hypoxia on cortical thickness, (for each trimester, pregnancy in total, and 
labour, a combined OCs score, a continuous OCs score, a severe OCs score, and a 
hypoxia score). First, analyses of case-control differences (without OCs scores) were 
conducted with thickness as the dependent variable and age as covariate. Second, 
analyses were conducted for each of the nine OCs scores in patients and controls 
separately, with age as a covariate. None of the obstetric variables differed between 
patients and controls. 
Significant cortical thinning in schizophrenia patients, as compared to healthy control 
subjects, was demonstrated for the temporal pole and superior temporal gyrus 
bilaterally, in the left hemisphere superior frontal gyrus, and in the right hemisphere 
planum temporale, insula, and superior orbital gyrus, after multiple comparison 
control by FDR. 
No significant relationships between any of the nine OCs scores and cortical thickness 
were found in either patients or controls.  
In conclusion, even by testing a broad range of OCs measures, no relationships 
between OCs and cortical thickness were found. This result suggests that OCs, at the 
current levels of severity, do not explain the thinner cortices found in the present 
sample of patients with schizophrenia as compared with healthy controls.  
 
Study 3 
“Cortical folding in Broca’s area relates to obstetric complications in 
schizophrenia patients and healthy controls.” 
Cortical folding occurs prenatally and remains by and large stable postnatally. Thus 
differences in cortical folding between schizophrenia patients and healthy controls 
may reflect aberrant pre-natal neurodevelopment in schizophrenia. We hypothesized 
(1) that OCs would be related to cortical folding as measured by a 3D surface-based 
local gyrification index (lGI), (2) that this relationship would differ in schizophrenia 
patients as compared to healthy control subjects. 
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First, case-control differences in the lGI were analysed, with age and gender as 
covariates. Two case-control analyses were performed, vertex-wise and as average 
measures of 34 pre-defined anatomical cortical areas (parcels) in each hemisphere. 
From the vertex-wise analysis, uncorrected results displayed reduced cortical folding 
in schizophrenia patients in an area corresponding to parts of the pre- and post-
central gyri bilaterally, and the right middle temporal gyrus (at p<0.01). No case-
control differences were demonstrated in any of the two analyses after proper multiple 
comparison control. 
Then, the relationship between OCs and lGI was analysed. Results from the vertex-
wise OCs analyses were suggestive of a relationship between a higher number of OCs 
and lower local GI in lower lGI in the left inferior frontal and prefrontal sulci and gyri 
at p-level of 0.01, but the findings did not survive FDR control for multiple 
comparisons.  
By analysing the average lGI in anatomical cortical parcels, a significant relationship 
between higher number of OCs and lower lGI in the left pars triangularis 
(corresponding to Brodman area 45 and parts of Brocas area) was found (p<0.0005, 
surviving Bonferroni correction). Five additional parcels in the left hemisphere 
demonstrated similar results; fusiform (p=0.011), lateraloccipital (p=0.037), 
parahippocampal (p=.007), pars opercularis (p=0.021), rostralmiddlefrontal (p=0.007). 
These five p-values did not remain significant after Bonferroni correction for 68 tests. 
There were no interaction effects between OCs and case-control status. 
In conclusion, lower cortical gyrification in the left pars triangularis of both 
schizophrenia patients and healthy control subjects demonstrated a statistically 
significant relationship with increased number of OCs after multiple comparison 
control. That reduced cortical folding in the left pars triangularis was associated with 
OCs in both patients and control subjects suggest that the cortical effect of OCs may 
be caused by factors shared between schizophrenia patients and healthy controls 
rather than factors related to schizophrenia alone. 
 
Study 4 
“An exploratory model for G x E interaction on hippocampal volume in 
schizophrenia; obstetric complications and hypoxia related genes” 
OCs and single nucleotide polymorphism (SNP) variation in schizophrenia 
susceptibility genes have independently been related to hippocampal volume. On 
account of hypoxia being a core feature of OCs and a strong modifier of gene 
expression, we hypothesized that the effect of OCs on hippocampal volume could be 
modified by variation in hypoxia-regulated genes, and tested the hypothesis for 32 
SNPs spanning 4 genes (DTNBP1, NRG1, GRM3, BDNF).  
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First, putative case-control differences in hippocampal volume were tested. Patients 
with schizophrenia demonstrated, on the average, 5% smaller hippocampal volume 
than healthy control subjects, and this reduction was present in both the left and 
right hemispheres (p=0.001)  
Second, the effect of OCs on hippocampal volume was analysed. The hippocampal 
volume was on the average larger in individuals with severe OCs, as compared to 
individuals without (p=0.048); the average effect was 3.6% independent of diagnosis 
(pdiagnosis*OCs=0.25). 
Third, the SNP x OCs interaction effect was explored. The larger hippocampal volumes 
observed in individuals with severe OC were significantly related to the GRM3 
rs13242038-T alleles (p=0.014), after adjustment for multiple testing).  
We re-analyzed a random sub-sample (n=60) of the study-group, using previous 
manual delineations of hippocampal grey matter volume (Agartz et al., 2006). In this 
sample, individuals who had experienced severe OCs (n=17) demonstrated smaller 
hippocampal grey matter volumes, with the volumes being 5.9% smaller. The mixed 
model analysis of GxE interaction in manually and automatically derived hippocampal 
volume confirmed that the effect of severe OC on hippocampal volume was dependent 
on rs13242038 genotype (pOCs*genotype= 0.004), and indicated that the interaction effect 
between OCs and the GRM3 locus differed between hippocampal volume 
measurements (pOCs*genotype*method = 0.016). For automatically-derived measurements, 
the larger hippocampal volume associated with severe OCs were only evident in 
individuals carrying the rs13242038 T-allele (p=0.026), whereas reduction in 
hippocampal grey matter associated with severe OC was only evident in individuals 
who were homozygous for the rs13242038 C-allele (p=0.041).  
In conclusion, the effect of severe OCs on hippocampal volume was associated with 
allele variation in GRM3 rs13242038 in both schizophrenia patients and healthy 
controls, but the result must be interpreted with caution due to the limited subject 
sample size. 
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5. Discussion 
 
To summarize, the main results from the four studies included in this thesis were: 
1. Occurrence of OCs and representativity: 
Rate or severity of OCs did not differ between schizophrenia patients and healthy 
control subjects. The full range of OC were represented in both groups. 
2. No evidence of association with OCs: 
A history of OCs did not affect basal ganglia volumes (study I) or cortical thickness 
(study II). 
3. Evidence of associations with OCs: 
OCs affected cortical folding in the left pars triangularis (study III). The hippocampal 
volumes (study IV) demonstrated a significant association with OCs.  
4. Effect of gene x OCs interaction: 
The effect of OCs on hippocampal volume appeared to be modulated by allele variation 
in the hypoxia-regulated GRM3 gene (study IV) 
5. No specific effects of OCs in schizophrenia patients: 
The findings were equal in patients and healthy controls. There was no evidence that 
brain morphology in patients with schizophrenia was more or differently affected by 
OCs than in healthy controls. 
6. Case-control differences in brain morphology 
Schizophrenia patients demonstrated significantly larger globus pallidum volumes 
(study I), prefrontal and temporal cortical thinning (study II), smaller hippocampal 
volumes (study IV), and near significantly lower cortical folding in the pericentral 
cortex (study III), when compared to healthy controls. 
 
In this section I will first address the significance of the results from the four studies 
included in this thesis by discussing them in the light of previous empirical findings 
(5.1). Then I will consider theoretical aspects of how the current findings may 
contribute to the understanding of the relationship between OCs and brain structure 
in schizophrenia (5.2). Methodological issues, including strengths and limitations in 
the four current studies, will be discussed (5.3), before I will add some final comments 
on biological causality (5.4).  
 
5.1. Comparisons to previous empirical findings 
5.1.1 Effects of OCs on brain morphology 
Contrary to our expectations, two of the current studies reported negative results; no 
associations were demonstrated between OCs and basal ganglia volume (study I) and 
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cortical thickness (study II). Both studies are, to the best of our knowledge, the first 
scientific studies to investigate the hypothesized associations. The current negative 
results need to be replicated in independent samples. 
In study I, no relationship was found between OCs and basal ganglia volumes 
(accumbens, caudatus, pallidum, and putamen) in either schizophrenia patients or 
healthy controls. Animal models have demonstrated that OCs such as caesarean 
section (El-Khodor & Boksa, 2001) and perinatal anoxia (El-Khodor & Boksa, 1997) 
have the propensity to alter striatal dopamine metabolism (Berger et al., 2000;Winter 
et al., 2008), and striatal cytoarchitecture (Bernert et al., 2003;Juarez et al., 2008). 
This study indicate that previously reported alterations of basal ganglia volumes in 
first-episode schizophrenia (Ebdrup et al., 2010;Ellison-Wright et al., 2008) are 
caused by other factors than OCs. Such factors may be related to neurodevelopment 
(Glenthoj et al., 2007), genes (Rajarethinam et al., 2007), or the disease process itself. 
In accordance with our findings, Bersani and colleagues reported no effect of OCs on 
the bicaudate ratio (an indirect measure of caudate/ventricle size) in (n=47) male 
schizophrenia patients (Bersani et al., 2009).  
From animal models, the strongest effect of OCs on basal ganglia structure and 
function was an accumbens effect (El-Khodor & Boksa, 1997;Juarez et al., 2008). The 
current results demonstrated a relationship between increasing number of OCs and 
larger volume of nucleus accumbens that was not significant after multiple 
comparison control. The importance of this almost significant finding is uncertain. 
The borders of the nucleus accumbens are difficult to delineate on MR images, both 
automatically and manually obtained measurements have sub-optimal validity (see 
5.3.3). This may have affected the findings. In addition, important confounding factors 
include effects of the long illness duration among the schizophrenia patients (mean 
duration was 17.8 years), and the long-term use of antipsychotic medication, known 
to affect basal ganglia volumes (Scherk & Falkai, 2006;Smieskova et al., 2009), that 
may both have masked subtle volume alterations related to OCs. Basal ganglia volume 
did, however, not differ between patients using typical, atypical, or no antipsychotic 
medication.  
 
In study II, no relationships between nine different OCs constructs and cortical 
thickness were found in either schizophrenia patients or healthy controls. Cannon et 
al. (2002b) have previously reported that foetal hypoxia predicted smaller grey matter 
cortical volume, most prominent in the temporal lobe, in 64 schizophrenia patients 
and their healthy siblings (n=51) but not in healthy control subjects (n=54) in a ROI 
based study from Finland. An explanation as to why the present findings differ from 
those of Cannon et al., even though the same definition of foetal hypoxia was used, is 
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likely to be that cortical thickness and grey matter volume measures address different 
properties of the cerebral cortex. Reduced cortical volumes may be caused by reduced 
cortical thickness or cortical area or both (from the equation cortical volume= cortical 
thickness  cortical area) (Voets et al., 2008). The use of a state-of the-art-method 
such as FreeSurfer that measures cortical thickness at submillimeter intervals across 
the whole cortical mantle, makes for high accuracy in anatomical localisation and 
extent of pathological changes, and cortical thickness effects of OCs should have been 
found if they existed. The differing results form our and Cannon et als. (2002b) study 
may reflect cohort effects, or the results form Cannon et als study may have been 
caused by effects on cortical area and not on thickness.  
Other factors that have been reported to influence on cortical volume or cortical grey 
matter density, such as duration of illness (Sun et al., 2009;van Haren et al., 2007) 
and medication use (McClure et al., 2006), could potentially have affected the results. 
Medication use has, however, previously been studied in a larger subject sample 
(n=203) which included the present (n=108), and did not show any effect on cortical 
thickness (Nesvag et al., 2008) or cortical volumes (Nesvag et al., 2007).  
The current findings indicate that the cortical thinning observed in studies of 
schizophrenia occurs independently of OCs, and that OCs with the current severity do 
not cause cortical thinning as reported in adolescents with very low birth weight 
(VLBW) (Martinussen et al., 2005), or in children exposed to maternal opiate abuse in 
utero (Walhovd et al., 2007).  
 
The timing of the origin of the cortical thinning in schizophrenia in uncertain. Cortical 
folding abnormalities may originate from the prenatal period as the pattern of cortical 
folding is known to be by and large completed at birth (Armstrong et al., 1995). In 
study III we report a significant relationship between increasing number of OCs and 
lower cortical folding in the left pars triangularis (Broca’s area) in both schizophrenia 
patients and healthy controls. In addition, associations between OCs ad cortical 
folding, in the same direction, were found in five other parcels in the left hemisphere, 
but did not remain significant after strict Bonferroni correction for multiple 
comparisons. 
The relationship between OCs and cortical folding in schizophrenia has previously 
been studied by Falkai et al. (2007) in a subject sample comprising 29 schizophrenia 
patients, 21 healthy family members, and 13 family members with other psychiatric 
illness. By using a two dimensional (2D) method6 and six coronal MRI slices, no 
                                                 
6 By using two dimensional methods the gyrification indec (GI) is calculated from coronal MRI slices 
or post-mortem brains by dividing the inner contour (along the pial surface) on the outer contour  
(following the brain surface).   
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relationship between OCs and cortical folding was demonstrated. The 3D surface-
based FreeSurfer method measures cortical folding at submillimeter intervals across 
the entire cortex, and has a greater sensitivity than the 2D method (Schaer et al., 
2008). The differing results from study III and Falkai et al’s (2007) study may either 
reflect a cohort effect, or they may reflect relationships between OCs and cortical 
folding that the use of a more sensitive method allowed us to detect.  
Taken together, the cortical findings from studies II and III suggest that cortical 
folding patterns are a more robust brain morphological correlate to early 
neurodevelopment (in the current studies in the form of OCs) than cortical thickness. 
That cortical thickness reductions appear to occur at a later stage than the pre- or 
perinatal period is in line with the findings from a previous study on cortical thickness 
and folding patterns in adolescents with psychosis (Janssen et al., 2009). Further 
support comes from Schaer et al. who have reported that congenital heart disease 
(presumed to cause lower oxygen delivery to the brain) in patients with 22q11 deletion 
syndrome was related to altered cortical folding patterns in the brain but not to 
cortical thickness (Schaer et al., 2009). 
The left pars triangularis is of particular interest as it is part of Broca’s area. Broca’s 
area is of importance to several cognitive domains including language formation 
(Bhojraj et al., 2009), semantic encoding (Demb et al., 1995), semantic retrieval (Badre 
& Wagner, 2007), syntactic processing (Friederici et al., 2003), and syntactic working 
memory (Fiebach et al., 2005). Disturbances in neurocognitive domains related to 
Broca’s area have been reported in schizophrenia ((Mesholam-Gately et al., 2009) for 
review) but also in preterm/WLBW children ((Arnoudse-Moens et al., 2009) for review), 
and in children suffering perinatal asphyxia (Stevens et al., 1999). In line with the 
present findings on brain morphology but concluded from studies of neurocognitive 
function, severe pre- and perinatal trauma appear to have adverse effects regardless if 
the subject develops schizophrenia, other psychiatric disorders, or remains healthy 
(Soria-Pastor et al., 2009;Nosarti et al., 2008). This emphasizes the importance of 
studying other factors that may (or may not) interact with OCs to affect brain anatomy 
in schizophrenia patients differently than in healthy controls. As heredity is an 
important risk factor for schizophrenia (Sullivan et al., 2003;Tsuang, 2000), it is of 
interest to study if genetic variation in molecular markers related to schizophrenia 
and/or neurodevelopment interact with OCs to affect brain anatomy in schizophrenia 
patients. 
 
To investigate such a model, in study IV, we explored a possible gene-environment 
interaction effect on hippocampal volume. It is to our knowledge the first study ever to 
investigate interaction effects of OCs and SNP variation (or any molecular markers) on 
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hippocampal volume (or any brain volume) in schizophrenia. Contrary to previous 
studies (Ebner et al., 2008;McNeil et al., 2000;Schulze et al., 2003;Stefanis et al., 
1999;van Erp et al., 2002), OCs caused larger hippocampal volumes independent of 
diagnosis when the FreeSurfer measurements were used. The measures include the 
hippocampal formation along with the fimbria white matter (Fischl et al., 2002;Makris 
et al., 1999;Morey et al., 2009). The previous studies, in which OCs caused smaller 
hippocampal volumes, used volume measures of the hippocampus proper which 
included mainly hippocampal grey matter and excluded the fimbria (Ebner et al., 
2008;McNeil et al., 2000;Schulze et al., 2003;Stefanis et al., 1999;van Erp et al., 
2002). The contradictory results could be caused by OCs having a differential effect on 
grey and white matter, which has been suggested by findings from animal models; as 
a result of perinatal asphyxia, both neuronal degeneration in the hippocampal CA1 
region (grey matter) (Boksa, 2004;Rees et al., 2008), and hippocampal gliosis (white 
matter) (Bernert et al., 2003) have been reported. In addition, prenatal hypoxia has 
been demonstrated to exert a different effect on grey and white matter depending on 
the timing as well as the severity of the hypoxic insult (Rees & Inder, 2005). In the 
subset (n=60) of the current subject sample, OCs were related to smaller volumes of 
the grey matter in hippocampus proper (as obtained by manual delineations). In this 
subset, the automated hippocampal formation volume measures (from FreeSurfer) 
remained larger in subjects with a history of OCs, which is a finding that excludes 
that a cohort effect would explain the results. This is supportive of a possible 
differential effect of OCs on grey and white matter that needs to be further 
investigated.  
The suggested modulating effect of SNP variation in the GRM3 rs13242038 allele on 
the association between OCs and hippocampal volume was present for both the 
hippocampal formation (FreeSurfer measure) and the hippocampus proper (manual 
delineations), regardless of diagnostic group. The finding finds support by results from 
an animal models in mice where antenatal hypoxia caused a 2-4 fold reduction in 
mGluR3 expression (the receptor encoded by the GRM3 gene), and the down-
regulation in gene activity was linked to a decreased vulnerability to hypoxia-induced 
white matter damage (Fontaine et al., 2008). The same response was not found in 
rats, which may suggest that genetic factors underlie GRM3 regulation and the 
susceptibility to white matter damage in rodents. OCs-gene interaction effects on 
hippocampal volume are supported by a different animal model, where prenatal 
infection have been demonstrated to alter gene-expression and affect hippocampal 
volume in rats (Fatemi et al., 2009). 
The findings from study IV must be considered to be preliminary because of the 
relatively limited sample size, and the fact that the rs13242038 polymorphism, 
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located in the first intron of the GRM3 gene, has no known function. However, the 
findings are plausible given the results from the animal models (Fatemi et al., 
2009;Fontaine et al., 2008), and the biological fundament for an interaction effect 
between OCs (with hypoxia) and allele variation in genes regulated by hypoxia (such 
as GRM3) (Nicodemus et al., 2008;Schmidt-Kastner et al., 2006). The GRM3 gene has 
been reported to be involved in neurodevelopment (Harrison et al., 2008;Melchiorri et 
al., 2007). mGluR3 is expressed in the hippocampus (Lyon et al., 2008), and receptor 
expression has been reported to be altered following transient brain ischemia 
(Raghavendra Rao et al., 2002).  
The fact that the current OCs-gene interaction effect was present in both 
schizophrenia patients and healthy controls suggests that hippocampal vulnerability 
to severe OCs could be influenced by factors independent of those related to 
schizophrenia pathogenesis; the effect may be modified by SNP variation in genes that 
are associated with schizophrenia risk (e.g. the GRM3 gene) but also occurs in 
subjects without the illness. The effect of OCs on hippocampal volume in siblings of 
schizophrenia patients has been reported to be different from the effect in the 
schizophrenia patients, but the interaction with diagnostic group was not statistically 
significant (van Erp et al., 2002). In another study, OCs were associated with reduced 
hippocampal volume also in the relatives (mothers/fathers/siblings) of schizophrenia 
patients (Ebner et al., 2008). The effects of OCs on hippocampal volume may be 
associated with shared genetic underpinnings of both hippocampal volume 
vulnerability to OCs and of schizophrenia susceptibility. 
 
5.1.2 Differences in brain morphology and frequency of OCs between schizophrenia 
patients and healthy controls  
One of the aims of this thesis was to explore if case-control differences in brain 
morphology between schizophrenia patients and healthy controls could be attributed 
to a history of OCs. In all four studies, patients demonstrated brain anatomical 
abnormalities as compared to healthy controls. Patients demonstrated significantly 
larger globus pallidum volumes (study I), which is in line with previous studies 
(Brandt & Bonelli, 2008;Mamah et al., 2007). We also found thinner cortices (study II) 
in schizophrenia patients in the left and right hemisphere temporal and frontal lobes, 
the same regions as in a previous study from our group of a larger subject sample 
(n=203) that included the present (Nesvag et al., 2008), and in line with other previous 
studies (Goldman et al., 2009;Kuperberg et al., 2003;Schultz et al., 2010). Since no 
effects of OCs on either basal ganglia volume or cortical thickness were found in study 
I and II, we can conclude that the case-control differences in basal ganglia volume and 
cortical thickness appear to be unrelated to a history of OCs with the current severity.  
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In study III, significant cortical folding differences between patients and controls were 
present in parts of the pericentral cortex bilaterally, and in the right middle temporal 
gyrus, before controlling for multiple comparisons. Although no statistically significant 
case-control differences remained after such control, a larger study of 400 subjects 
(including the present sample) by our research group demonstrated significantly 
reduced cortical folding in parts of the left pericentral cortex (Nesvåg et al., in prep) 
this corresponding to the case-control differences in the current smaller subject 
sample. The effect of OCs on cortical folding in study III was, however, located in a 
different brain region (the left pars triangularis) than the case-control differences. The 
findings from this study indicate that subjects with both schizophrenia and OCs have 
reduced cortical folding both in the left pars triangularis and in the left pericentral 
cortex. Accordingly, if (a) schizophrenia disease per se is related to abnormal brain 
morphology independently of OCs, and OCs both (b) increase the risk for 
schizophrenia (as generally demonstrated in the literature (Cannon et al., 2002a)), and 
(c) are also independently related to other brain morphological abnormalities, then 
schizophrenia patients may – in a larger context – tend to be subjected to at least a 
double “dose” of  brain morphological abnormalities, even if the “doses” result from 
separate factors.  
Further evidence for independent effects of OCs and diagnosis on brain morphology 
can be inferred from study IV. Patients had smaller hippocampal volumes when 
compared to control subjects, which is a consistent finding in previous scientific 
studies (Ebdrup et al., 2010;Honea et al., 2005;Shenton et al., 2001). In the current 
study, OCs were related to larger (when measured by FreeSurfer) and smaller (when 
measured by manual delineation) hippocampal volumes regardless of diagnostic 
group. This suggests that case-control differences in hippocampal volume in the 
current study are not related to OCs. To sum up, all four studies included in the 
thesis indicate that case-control differences in the investigated brain structures 
cannot be attributed to OCs. 
 
In the current subject sample, schizophrenia patients and healthy controls had the 
same frequency of OCs, and the same obstetric characteristics e.g. birth weight, 
gestational age, or maternal age. This is in contrast with the large epidemiological 
studies that report significant case-control differences in birth weight (Nilsson et al., 
2005), low birth weight in combination with low gestational age (Jones et al., 1998), 
and obstetric complications such as perinatal asphyxia (Dalman et al., 2001) and 
maternal bleeding (Hultman et al., 1999). However, in previous clinical studies with 
subject sample sizes comparable to ours, there were no significant differences in birth 
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weight (Onstad et al., 1992) or in the frequency a variety of different OCs (Kendell et 
al., 2000) between schizophrenia patients and healthy controls.   
The frequency of OCs in the current schizophrenia group and healthy controls is 
within variance reported in studies of OCs and brain morphology and OCs-gene 
interaction (see Table 3). Importantly, within both schizophrenia patients and healthy 
control subjects, OCs occurred with a high enough frequency to detect their effects on 
brain morphology, if such effects exist (and they do in study III and IV). 
 
Table 3. Number with OCs in each group in previous studies ingestigating the relationship between 
OCs and brain morphology or OCs-gene interaction in schizophrenia (scz), siblings and controls. 
Studies included in the list are those where number of subjects and OCs were clearly stated.  
Author Subject sample OCs definition Number with OCs Comment 
Cannon et al, 
2002 
64 scz patients, 
51 siblings, 54 
controls 
Hypoxia by 
own definition  
15 (23%) of scz patients, 
13 (25%) of siblings, and 
12 (22%) of controls 
Hypoxia 
definition similar 
to ours in study 
II 
Ebner et al., 
2008 
30 scz patients, 
34 siblings 
McNeil-
Sjöström scale 
Pregnancy:19 (63%) of 
patients, 25 (74%) of 
siblings. Labour: 12 
patients (40%)  and 
15 (44%) siblings 
Neonatal:  22 (73%) 
patients and 20 (59%) 
siblings  
OCs cut-off at 
severity level 3 
Falkai et al., 
2007 
29 scz patients, 
13 siblings with 
psychiatric 
disorder, 21 
healthy siblings 
McNeil-
Sjöström scale 
 
Average OCs number 
was 2.10 for scz 
patients, 3.23 for 
patients with psych. 
disorder, and 2.29 for 
healthy siblings 
Number of 
complications  
equal or > 3 
Nicodemus et 
al., 2008 
116 scz patients McNeil-
Sjöström scale 
29 (25%) of scz patients Cut off at severity 
level 5, as in our 
study IV 
Schulze et 
al., 2003 
110 subjects in 
total, comprising 
scz patients, 
relatives , and 
controls 
Lewis–Murray 
scale 
18 % of familial scz 
probands, 62% of non-
familial scz probands, 
19% of familial relatives, 
13% of non-familial 
relatives, and 19% of 
controls 
OCs recorded as 
definite. 
 
 
5.2 Theoretical considerations from the empirical findings 
The reported findings are internally consistent in that the effects of OCs on brain 
morphology had equal distribution in schizophrenia patients and healthy controls in 
all four studies, and when effects of OCs were found, they were not related to case-
control differences (study III and IV). Obviously, caution must be exercised when 
51 
 
attempting to infer theoretical conclusions of the empirical findings from one subject 
sample. The points raised below illustrate how the current findings may be relevant to 
the understanding of possible relationships between OCs and brain structure in 
schizophrenia, but they are by no means conclusive. 
When designing the current studies, our initial hypothesis and model for all studies in 
this thesis was that the brain morphological abnormalities observed in schizophrenia 
patients, as compared to healthy controls, could be attributed to abnormal 
neurodevelopment resulting from OCs (as illustrated in figure 5). If this were true, 
then OCs would correspondingly be expected to be more frequent or more severe in 
the schizophrenia group, or possibly cause a negative effect on the brain through an 
interaction with schizophrenia susceptibility genes or other factor not known.  
 
Figure 5. The hypothesised model of the relationship between OCs, schizophrenia, and brain 
morphological abnormalities  
OCs
schizophrenia
OCs related brain
morphological 
abnormalities
schizophrenia related
brain morphological 
abnormalities 
 
 
The empirical findings from the current studies supported, however, a different model 
(illustrated in figure 6). We found that OCs either had no effects on brain morphology 
(studies I and II) or affected brain morphology (studies III and IV) in different regions 
(study III) or in a different direction (study IV) than would fit with causing the case-
control brain differences. 
 
Figure 6. The empirical model of the relationship between OCs, schizophrenia, and brain 
morphological abnormalities, based on the findings from the studies included in the current thesis  
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When discussing the current findings, the “equifinality” and “multifinality” concept 
may be of use.  
Equifinality describes a phenomenon where several different developmental processes 
or distinct causes can lead to the same outcome (Waldman, 2003). If “the outcome” is 
defined as schizophrenia, the current findings of equal distribution of OCs within the 
patient and control groups do not support OCs acting alone to be part of an 
equifinality pathway for schizophrenia, although we cannot exclude the possibility 
that the current studies were underpowered to detect such a putative association (see 
5.3.4). If the broader class of brain morphological abnormalities is defined as “the 
outcome”, then the current findings support brain morphological abnormalities in 
schizophrenia and abnormalities related to OCs to be the results of different 
equifinality pathways. With both definitions of the outcome, the equifinality concept 
cannot be meaningfully used to understand or interpret the implications of the 
current findings.  
Multifinality describes a phenomenon where one particular developmental process or 
distinct cause can lead to a variety of outcomes (Waldman, 2003). Multifinality can be 
constructed as an example of moderation, where the relation between a cause and the 
outcome depends on other variables (or moderators). Within this concept, OCs can be 
defined as “one particular process” involved in the pathogenesis of either 
schizophrenia  (Rapoport et al., 2005), other psychiatric (Verdoux & Sutter, 2002) or 
somatic disorders (Gluckman et al., 2008), or they may lead to no illness at all 
(multifinality) if the outcome measures are health or diagnostic status. If the outcome 
measure is brain morphology, the current findings demonstrate a variety, with no 
effect of OCs on some of the structures analysed (the cortical thickness and basal 
ganglia volumes), but an effect on other structures (cortical folding and hippocampal 
volume). Within this framework, OCs may affect brain structure in both schizophrenia 
patients and healthy controls, because the variation in outcomes is not defined to 
include diagnosis. The concept can be used to interpret the current findings as 
specific with regard to OCs, but non-specific with regard to schizophrenia. Such an 
interpretation opens the possibility for other genetic and environmental factors, in 
addition to or in interaction with OCs, to be of importance for the development of 
schizophrenia or abnormalities of brain morphology as described in schizophrenia. 
A distinction between “the deficits model” and “the risk model” for outcomes of early 
developmental trauma has been postulated from studies in primate species 
(Schneider, 2003). The “deficits” model describes cause-effect relationships wherein 
specific early life events result in pathology later in life. In contrast, in the “risk model” 
specific early life events, along with other events, are considered as probabilistic 
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contributors to altered developmental outcome, in an dynamic and complex 
interaction process (Schneider, 2003). The risk model is related to multifinality. It is 
consistent with a theoretical framework supported by the current findings, where OCs 
may cause brain morphological alterations, but where the association with 
schizophrenia risk and pathology, if existent, appears to be a result of interaction with 
genetic variation or other risk factors, rather than effects of OCs alone. With regards 
to the theoretical framework for this thesis, the current findings do not directly 
contradict the neurodevelopmental hypothesis of schizophrenia, as the hypothesis 
does not postulate OCs to be the sole cause of the brain morphological alterations 
observed in schizophrenia (Fatemi & Folsom, 2009;Lewis & Murray, 1987;Rapoport et 
al., 2005;Weinberger, 1987).  
 
5.3 Methodological issues 
5.3.1 Pre and perinatal complications  
The assessment of OCs in adult schizophrenia faces methodological challenges. First, 
information on pregnancy and delivery complications as collected from mothers 
(maternal recall) have been demonstrated to be inaccurate (Buka et al., 2004;Cantor-
Graae et al., 1998). Mothers of schizophrenia patients report a higher level of 
complications than what had been described in the corresponding birth records 
(McIntosh et al., 2002). This bias has been avoided in the present thesis by using 
original birth records as the information source on obstetric events. The use of data 
from historical sources (in this case hospital birth records) distinguishes “follow-back” 
from “retrospective” studies  (Keshavan, 2003). The obstetric journals provide 
accurate information on diagnosis and medical interventions (including medication) 
given throughout pregnancy and labour.  
Information on environmental factors of putative harm to the foetus may, however, 
have been missing. Maternal smoking through pregnancy was recorded for two 
mothers, all others were scored as non-smokers; this may constitute a limitation since 
it is not certain whether or not these mothers were true non-smokers or not. Prenatal 
nicotine exposure has been demonstrated to be related to schizophrenia risk in one 
study (Zammit et al., 2009), but not in others (Ellman et al., 2007;Baguelin-Pinaud et 
al., 2010). In utero nicotine exposure have been demonstrated to decrease total 
number of cells in the brain (Dwyer et al., 2009). Furthermore, exposure to 
environmental toxins and alcohol consumption among mothers was not systematically 
recorded. This constitute a limitation, since in utero alcohol exposure has been related 
to a variety of brain morphological alterations, some of which are hippocampal and 
basal ganglia volume reductions (Norman et al., 2009). Severe hunger was not present 
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in Sweden during the period when the study subjects were born; if their mothers had 
been severely malnourished, this would have been recorded in the medical birth 
records. Despite the problems of possibly missing data, the use of birth records as the 
source of obstetric information is generally acknowledged to be superior to maternal 
information because of the problems of recall bias in the latter. 
Second, uncertainty exists as to how one should rate and value the various OCs  
occurring in any sample (McNeil et al., 1994). As described in chapter 1.4, several 
different complications, e.g. perinatal asphyxia, maternal infection, and low birth 
weight, have been demonstrated to increase schizophrenia risk (Cannon et al., 
2002a;Dalman et al., 2001;Hultman et al., 1999;Nilsson et al., 2005;Rosso et al., 
2000), and different complications may be inter-related. In clinical samples, individual 
complications occur too infrequently to permit assessing their effect separately. For 
instance, severe prematurity was present in three subjects in the current sample. To 
facilitate studies of OCs in clinical samples, scales that add and/or grade different 
complications have been constructed, e.g. the McNeil-Sjöström scale (McNeil & 
Sjostrom, 1995) and the Lewis-Murray scale (Lewis et al., 1989). The McNeil-Sjöström 
scale is the more comprehensive, it allows testing of different stages of the gestational 
process, and it has been demonstrated to be the most sensitive scale  
Third, it may prove difficult to define the optimal or correct cut-off level in 
dichotomous OCs constructs, or to decide if continuous or dichotomous variables are 
the most appropriate. By grouping subjects into exposed or non-exposed, potential 
dose-related effects may be obscured (Mayes & Ward, 2003). By defining cut-offs, one 
implies that complications above the cut-off threshold have a qualitatively different 
effect on the studied structure (in the case of MRI studies) or on schizophrenia risk (in 
the case of risk studies). The biological correlates of such thresholds may be valid, e.g. 
as presence or absence of a diagnosis of asphyxia, or more uncertain e.g. when a birth 
weight of 2500 g is categorised as a non-complication and 2499 g is categorised as a 
complication. Cut-off scores were used in study II and study IV to enable comparisons 
of our results with results from other studies (Cannon et al., 2002b;Nicodemus et al., 
2008). Nevertheless, in study II, the use of cut-off scores was supplemented by a 
continuous variable that also showed negative results. Thus in studying OCs, it 
remains to be determined in general whether it is more appropriate to use continuous 
or dichotomized OC scores, how to decide on valid cut-offs for dichotomized scores, 
and whether and how different OCs should be combined into larger constructs.  
 
5.3.2 The schizophrenia diagnosis and concept 
Schizophrenia is a broad diagnostic entity. The schizophrenia diagnosis is 
atheoretical, and based on the presence of clinical symptom criteria (American 
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psychiatric association, 1994). The scientific validity of the schizophrenia diagnosis 
has been discussed (Blom 2003; Keshavan 2008). Epistemic values, that is values 
needed for a scientific construct to be valid, include: internal coherence, external 
consistency, predictive accuracy, fertility, simplicity and validity (Blom, 2003). The 
operationalisation of diagnostic criteria (i.e. descriptive criteria such as in DSM-IV) 
has increased the reliability of psychiatric diagnostics (Fulford et al., 2006). Three 
acknowledged aspects of heterogeneity in schizophrenia are the aetiology, phenotype, 
and biology of the illness (Keshavan et al., 2008). This challenges the internal 
coherence of the diagnosis.  
The interpretations of the current findings rely on the schizophrenia group to be a 
valid construct that is distinct from the group of healthy controls. This was, as far as 
clinically possible, ascertained by the thorough diagnostic procedures in the HUBIN 
study. The diagnostic procedures have been validated by comparing the structural 
interviews with psychiatric records and register data (Ekholm et al., 2005;Vares et al., 
2006), and the diagnostic concordance rate between three psychiatrists was good to 
excellent (Ekholm et al., 2005).  
The heterogeneity of the illness may account for the fact that effects of various OCs on 
e.g. brain morphology and schizophrenia risk are small and non-consistent. Of 
relevance to the current studies, the phenotypic heterogeneity regarding clinical 
symptomatology may reflect exposure to OCs and genetic variation. There is some 
evidence that a history of OCs is related to clinical features/sub-groups of 
schizophrenia. Patients with a high score of negative symptoms (as recorded by 
PANSS) have been demonstrated to have significantly higher prevalence of OCs when 
compared to patients with low PANSS scores (Ruiz-Veguilla et al., 2008), and more 
OCs and lower Apgar score than patients with predominantly positive symptoms 
(Kotlicka-Antczak et al., 2001). OCs have also been related to earlier age of illness 
onset (Cannon et al., 2000;Verdoux et al., 1997). Thus the results from the current 
four studies might have been different if we had studied only the patients with a high 
prevalence of OCs and an earlier age at onset, and also if we had studied another 
subject sample with different clinical characteristics and exposure to OCs. 
 
5.3.3 MRI acquisition and post-processing 
MR images are digital reconstructions of which the quality is dependent on e.g. 
scanner properties and pulse sequence parameters. In clinical studies, it is of 
importance to use the same scanner and scanner parameters for all subjects, and to 
avoid scanner upgrades during the period of the data collection. By scanning patients 
and control subjects concurrently potential false case-control differences caused by 
scanner drifting can be avoided. All these precautions were taken during the 
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acquisition of the MR images used in the current studies. Motion and flow artefacts, 
caused by blood flow or CSF circulation, may occur on MR images of the brain. In the 
present studies we used Gradient echo (GRE) sequences, which to some extent 
prevent CSF pulsation artefacts (Weishaupt et al, 2003).  
The main image post-processing method was FreeSurfer. Cortical reconstruction (in 
study II and III) by this method is accurate and extremely detailed (Kuperberg et al., 
2003;Schaer et al., 2008). For sub-cortical segmentation, reliability has been 
demonstrated to be good for the hippocampus, caudate, putamen, and pallidum 
volumes (Fischl et al., 2002;Morey et al., 2009) and across within-scanner multiple 
acquisitions (Jovicich et al., 2009). The FreeSurfer volume measures of ICV 
accumbens are more problematic.  
The ICV measure in FreeSurfer is obtained from T1-weighted images only. The 
contrast between CSF and the surrounding tissue is ideal when both T1 and T2 
weighted images are used. Accordingly, measurements of ICV from T1 and T2 images 
as obtained by the software BRAINS was used in studies I and IV. The use of two 
different MRI post-processing methods may have affected the results from study I and 
IV. 
The borders of nucleus accumbens are difficult to delineate, both automatically and 
manually, due to its anatomy. In the anterior aspect, artefacts of the lateral ventricles 
are hard to differentiate from the boundary of the nucleus accumbens, and in the 
posterior aspect, it is difficult to discriminate the boundary between the nucleus 
accumbens and the substantia innominata because of their contiguity (Tamagaki et 
al., 2005). The low correlation between the automated and manual accumbens 
volumes  (see 3.3.3) indicate that the lack of effect of OCs on accumbens may be less 
reliable than for putamen and caudate (Study I).  
 
5.3.4 Statistics 
In all studies linear associations between OCs and brain structure have been studied, 
by the use of linear regression (studies I and III), a general linear model (studies II and 
III), and a mixed linear model (study IV). Thus, we cannot exclude that non-linear 
relationships may have been overlooked.  
In studies I and IV, where subcortical structures were investigated, intra cranial 
volume (ICV) had to be controlled for. ICV was highly correlated with gender in the 
current subject sample. To avoid problems of multi-collinearity, gender was excluded 
as a variable. Gender did, however, not affect the basal ganglia or hippocampal 
volumes, when ICV was included in the full models.  
In order to minimize the risk for false positive findings, the use of a proper method for 
multiple comparison control is of importance. Multiple comparisons correction in the 
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current studies was performed with different methods, that reflect the characteristics 
of the analyses in each study. The Bonferroni method7 (study I and III) has a strong 
control of type I errors, but the method has been argued to be too conservative, at 
least when more than five tests are performed (Altman, 1991). Thus, the use of 
Bonferroni correction in study I with only four tests appear appropriate, giving a new 
p-value threshold of 0.05/4= 0.0125. By applying this correction, the relationship 
between increasing number and severity of OCs and larger accumbens volume did not 
remain statistically significant. In study III with 68 tests the Bonferroni method of 
correction may have been too strict, giving a new significance threshold at 0.05/68= 
0.00074. Still, the relationship between increasing number of OCs and lower local 
gyrification index in the left pars triangularis remained significant. Applying a 
Bonferroni-Holm8 correction in study III did not alter the number of parcels in which 
OCs were significantly related to lower cortical folding.   
In the cortical surface analyses (studies II and III), as many as 162 000 tests were 
performed in each hemisphere, that is one test for each vertex across the cortical 
mantle. The Bonferroni method has been reported to be too sensitive for this kind of 
analysis (Genovese et al., 2002). The false discovery rate (FDR) for multiple 
comparison control incorporated in the FreeSurfer analysis algorithms was applied for 
the FreeSurfer studies (studies II and III). With this method the significance threshold 
is determined not by number of tests, but by the results, where 5% (at an FDR 
threshold of 0.05) of the p-values below a given threshold (e.g. 0.01) are expected to be 
false. Thus the FDR corrected threshold will vary with number of findings.  
For the genetic analyses in study IV, multiple comparison control was done by 
permutation testing, a method that has been recommended for genetic association 
analyses (Dudbridge, 2008;Westfall & Young, 1993).  
In all clinical studies, the risk of type II errors needs be balanced with the risk of type 
I errors9. As we have applied relatively strict multiple comparison corrections, there is 
a possibility that positive associations between OCs and brain morphology, that would 
have been found in a larger subject sample, may have been overlooked. Also, the 
power to detect differences in exposure to OCs between schizophrenia patients and 
healthy controls was only 37% (given an expected OR of 2 for schizophrenia with a 
history of OCs (Clarke et al., 2006), and a frequency of OCs of 25%). 
                                                 
7 The Bonferroni corrected significance threshold  is found by dividing the α level (in the current 
studies 0.05) on the number of tests performed (n), α/n. 
8 With the Bonferroni Holm method, the corrected threshold is found by  reducing n in the original 
α/n Borferroni correction by 1 for each observed p-value starting from the lowest (the one with the 
highest significance)  
9 Type I errors: the null hypothesis (H0) is rejected when it is in fact true, type II errors: the null 
hypothesis is not rejected when it is in fact false. 
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5.4 Comments on biological causality 
The reported effects of OCs on brain morphology in the current studies are all 
statistical effects, and do not establish biological causality. The hypotheses in this 
thesis were partly based on biological knowledge of harmful consequences to 
neurodevelopment caused by OCs from experimental animal models; OCs have the 
propensity to cause lasting brain morphological alterations in e.g. sheep (Rees et al., 
2008), rats (Fatemi et al., 2008), and monkeys (Short et al., 2010). Disturbed 
dopamine metabolism and disordered animal behaviour (Boksa, 2004) thought to 
parallel the disordered behaviour observed in schizophrenia have been reported as an 
effect of OCs exposure. However, translating findings from animal models explored in 
a controlled environment to findings in humans, in which environmental conditions 
are hard to control, is difficult. Even the most robust animal models of 
neurodevelopment and OCs effects face limitations since human brain development 
has a far greater complexity (Rees et al., 2008).  
In humans, MRI-studies of premature and low birth weight children and adolescents 
demonstrate a relationship between severe OCs and brain morphology (Kesler et al., 
2006;Martinussen et al., 2005). There is a possibility that the current findings are 
confounded by the relatively high age of the subjects included, and the long illness 
duration among patients. Nevertheless, age was co-varied for in the statistical 
analyses, and the findings were the same in healthy controls. The extended time 
between birth and age at study inclusion allows for exposure to factors that could 
potentially affect brain morphology, e.g. hormonal and epigenetic changes, or toxin-, 
drug-, and alcohol exposure. 
The gene-OCs interaction effects explored in study IV were based on biologically 
plausible hypoxia-related mechanisms (Schmidt-Kastner et al., 2006). However, the 
limitations above apply also to this study. Furthermore, two types of gene-
environment interplay exists; the genotype may correlate with the environmental 
experience (OCs), or the genotype may change the sensitivity to the environmental 
experience (Eaves et al., 2005). Either way of interplay may be an additional 
confounder of the biological plausible relationships that were investigated.  
59 
 
6. Conclusion and future directions 
 
From the four studies included in this thesis, it has been demonstrated that OCs 
affect certain aspects of brain morphology (hippocampal volume and cortical folding) 
whereas other aspects (cortical thickness and basal ganglia volumes) are unaffected 
by OCs of the current severity. Genetic variation may modulate the effect of OCs on 
hippocampal volume.  
The effects of OCs on brain morphology were the same in the patients with 
schizophrenia and the healthy control subjects, and differences in brain morphology 
between schizophrenia patients and healthy controls could not be attributed to a 
history of OCs.  
 
Suggestions for future research: 
The studies presented in the doctoral thesis raised a number of more spesific 
questions to be answered in future studies: 
Will the examination of single OCs (e.g. asphyxia, maternal infection) reveal effects on 
basal ganglia volumes and cortical thickness that were not found with the use of a 
combined OCs measure? 
Are there functional consequences of reduced cortical folding in Broca’s area in the 
form of neurocognitive disturbances? 
A possible differential effect of OCs on hippocampal grey and white matter needs to be 
further investigated. Is there a biological correlate?  
Does the G x E interaction effect between hypoxia-regulated schizophrenia 
susceptibility genes and severe OCs on hippocampal volume, replicate in a larger 
sample? Can interaction effects with genotypes of functional relevance be found? 
Is there an G x E interaction effect between severe OCs and genotype on brain 
structures that were not investigated? 
The effects of OCs on brain structure was similar in schizophrenia patients and 
healthy controls. Are there different OCs effects in the brain in patients with other 
diagnoses e.g. autism and anorexia (in which OCs may increase risk of disease), 
bipolar disorder (where OCs are not known to be related to increased risk) or somatic 
disease (e.g. hypertension or diabetes where adverse foetal events are known to affect 
disease risk)?  
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Abstract 
Background: The increased occurrence of obstetric complications (OCs) in patients with 
schizophrenia suggests that alterations in neurodevelopment may be of importance to the 
aetiology of the illness. Abnormal cortical folding may reflect subtle deviation from normal 
neurodevelopment during the foetal period. In the present study, we hypothesised that OCs 
would be related to cortical folding abnormalities in schizophrenia patients corresponding to 
areas where patients with schizophrenia display altered cortical folding when compared to 
healthy controls. 
Methods: Fifty-four schizophrenia patients and 54 healthy control subjects underwent 
clinical examination and MRI scanning on a 1.5 T scanner. Information on OCs was 
collected from original birth records. An automated algorithm was used to calculate a three 
dimensional local gyrification index (lGI) at numerous points across the cortical mantle. 
Results: In both schizophrenia patients and controls, an increasing number of OCs was 
significantly related to lower lGI in the left pars triangularis (p<0.0005) in Broca’s area. Five 
other anatomical cortical parcellations in the left hemisphere displayed a similar trend. No 
relationships between OCs and lGI were found in the right hemisphere, and no case-control 
differences in lGI were demonstrated.  
Conclusion: The reduced cortical folding in the left pars triangularis associated with OCs in 
both patients and control subjects suggests that the cortical effect of OCs may be caused by 
factors shared by schizophrenia patients and healthy controls rather than factors related to 
schizophrenia alone.  
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1. Introduction 
The increased prevalence of pre- and perinatal complications in schizophrenia patients is 
supportive of a neurodevelopmental origin of the illness (Lewis & Murray, 1987;Marenco & 
Weinberger, 2000;Weinberger, 1987). Subtle deviances from normal brain development may 
be reflected in altered brain morphology (Fatemi & Folsom, 2009). In schizophrenia patients, 
smaller hippocampi, larger ventricles, and reduced cortical thickness and volume have 
relatively consistently been reported (Glahn et al., 2008;Honea et al., 2005;Steen et al., 
2006). In animal models, various obstetric complications (OCs) have been demonstrated to 
cause both brain morphological alterations and behavioural aberrances that parallel those 
observed in schizophrenia ((Boksa, 2004) for review). In magnetic resonance imaging (MRI) 
studies of schizophrenia patients, OCs have been related to smaller hippocampi (Ebner et 
al., 2008;Schulze et al., 2003;van Erp et al., 2002), larger lateral ventricles (Falkai et al., 
2003;McNeil et al., 2000), and reduced cortical volume (Cannon et al., 2002). Taken 
together, these findings suggest that early somatic trauma such as OCs may exert an 
influence on neurodevelopment, detectable in the brain decades later. However, the brain 
morphological alterations reported in schizophrenia may also reflect medication use 
(Smieskova et al., 2009), illness progression (Tanskanen et al., 2008;van Haren et al., 2007), 
genetic variation (van Haren et al., 2008), or other illness-related factors. 
 
Alterations in cortical folding patterns may be a brain morphological correlate of aberrant 
neurodevelopment. The process of cortical gyrification is under genetic control (Piao et al., 
2004), but environmental factors have also been demonstrated to be of importance (Bartley 
et al., 1997). The early stages of gyrification appear around gestational week 16, with a rapid 
increase in cortical gyrification in the third trimester of pregnancy (Armstrong et al., 1995). 
The gyrification index (GI), defined as the ratio between the pial and the arachnoideal 
surface as observed in coronal slices of post-mortem brains or MRI scans (Zilles et al., 
1988), demonstrates a steady increase until post-natal week 6, from which the GI remains 
by and large stable (Armstrong et al., 1995). The human gyrification process may be a result 
of tension-based mechanisms. Viscoelastic tension exerted by cortical fibres draw regions 
with greater connectivity closer together (forming gyri) and thereby reduces the transit time 
of the action potentials (Van, 1997;White et al., 2010). Cortical folding patterns may thus 
convey information on underlying cortical organization and complexity. As a consequence, 
gyrification measures demonstrate properties related to both neurodevelopment and cortical 
organization, aspects that are of importance in schizophrenia.    
 
Several studies on gyrification abnormalities in schizophrenia have been conducted with 
heterogeneous findings as a result. Both prefrontal hypergyria (higher GI) (Falkai et al., 
2007;Harris et al., 2007;Vogeley et al., 2000;Vogeley et al., 2001) and lower prefrontal 
(Bonnici et al., 2007) and global (Cachia et al., 2008;Sallet et al., 2003) GI, as well as 
negative findings (Highley et al., 2003) have been reported. Gyrification abnormalities have 
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been reported to be present before adult illness onset (Harris et al., 2004a;Harris et al., 
2004b). A flattening of sulcal curvature along with peaking of gyral curvature has been 
reported in childhood- and adolescence-onset schizophrenia patients (White et al., 2003). It 
is however uncertain if early somatic trauma such as OCs influences the gyrification process 
in schizophrenia.  To our knowledge, thus far only one study has examined the relationship 
between OCs and gyrification in schizophrenia. Falkai et al. found no effect of OCs on a two-
dimensional (2D) based gyrification index in schizophrenia patients (n=29) and their 
relatives (n=21 healthy + 13 with psychosis)(Falkai et al., 2007).  
 
The human cortex is a highly complex three-dimensional (3D) structure. Measuring cortical 
folding from 2D coronal MRI slices, might lead to loss of information related to buried sulci 
and gyral anomalies in sublobar regions. In the present study we use a 3D surface-based 
automated algorithm to calculate the local gyrification index in each vertex across the whole 
cortical mantle (http://surfer.nmr.mgh.harvard.edu/fswiki/LGI) (Schaer et al., 2008). With 
this method, subtle localized deviances in cortical folding may be detected with greater 
precision.  
 
Hypotheses:  
Based on the previous literature, in the present study we hypothesised (1) that OCs would 
be related to cortical folding as measured by a 3D surface-based local gyrification index, (2) 
that this relationship would differ in schizophrenia patients and healthy control subjects, 
and (3) that the hypothesised difference would correspond to areas where schizophrenia 
patients demonstrate altered cortical folding as compared to healthy controls.  
 
 
2. Methods and materials 
2.1 Subject characterization  
This study was part of the Human Brain Informatics Project (HUBIN) at the Karolinska 
Institutet, Stockholm, Sweden. HUBIN is a comprehensive database of genetic, brain 
morphological, neuropsychological, and clinical information obtained from schizophrenia 
patients and healthy subjects. The subject inclusion took place between 1999 and 2003. All 
participants gave written informed consent. The project was approved by the Research 
Ethics Committee at Karolinska Institutet and the Swedish Data Inspection Board 
(“Datainspektionen”). The study was performed in accordance with the Helsinki Declaration. 
The subject sample consisted of unrelated Caucasian men and women currently resident in 
the Stockholm Area, and has previously been thoroughly described (Haukvik et al., 
2009;Jonsson et al., 2006). Briefly; invited patients from the out-patients clinic underwent a 
comprehensive clinical assessment protocol using validated operational instruments 
(Ekholm et al., 2005;Vares et al., 2006) including verification of diagnosis by a trained 
psychiatrist (EGJ). Handedness was ascertained by the means of asking the patients which 
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hand preference when writing, using a scissor and throwing/catching a ball. Patients 
fulfilled DSM-III-R or DSM-IV criteria for schizophrenia (n=50) or schizoaffective disorder 
(n=4).  
Control subjects were recruited from hospital staff, their relatives, or from a population 
register. The control subjects included in the present study were interviewed by the same 
trained psychiatrist (EGJ) and had no previous or current psychiatric disorders according to 
a semi-structured diagnostic interview. They were matched to the patients by age and 
gender (on a group level).  
Exclusion criteria for all subjects were a history of head trauma with loss of consciousness > 
5 minutes, current treatment for substance abuse, and/or somatic disorders affecting brain 
function. Demographic characteristics, duration of illness, age at onset, and use of anti-
psychotic medication are described in Table 1.  
 
2.2 MRI  
2.2.1 MR scan acquisition 
MR images were obtained at the MR Research Centre at Karolinska Institutet, Stockholm, 
Sweden, using a 1.5 Tesla GE signa Echo-speed (Milwaukee, Wis., USA) scanner. T1-
weighted images were obtained using a 3D spoiled gradient recalled (SPGR) pulse sequence 
with the following parameters: 1.5 mm coronal slices, no gap, 35 flip angle, repetition time 
24 ms, echo time 6.0 ms, number of excitations 2, field of view 24 cm, acquisition matrix 
256x192. All scans included were visually judged to be without obvious motion artefacts. A 
trained neuroradiologist evaluated all scans to be without gross pathology.   
 
2.2.2 MR scan post-processing 
First, cortical reconstructions were obtained from T1-weighted images using the automated 
computer software FreeSurfer version 3.0.2. Second, we used the lGI algorithm 
(http://surfer.nmr.mgh.harvard.edu/fswiki/LGI) to compute vertex-wise measurements of 
local gyrification at thousands of vertices across the cortical mantle. In addition, 
measurements of the average local gyrification index were calculated in 34 pre-defined 
anatomical cortex parcellations (Desikan et al., 2006) in each hemisphere (Table 2). The lGI 
method is adapted from the classical gyrification index (2D-GI), which is the ratio of the total 
pial cortical surface over the perimeter of the brain delineated on coronal sections. The 
present method, lGI, iteratively quantifies GI in circular three-dimensional regions of 
interest. After the creation of an outer envelope that tightly wraps the pial cortical surface, 
local measurement of circular GI is computed for each vertex of the outer surface as the 
ratio of corresponding regions of interest (ROI) on the hull and pial meshes is created. 
Delineation of the ROI on both the outer surface (ROIO) and pial surface (ROIP) uses a 
matching algorithm based on geodesic constraints, so that the ROIP takes into account the 
entire patch of the cortical surface delineated by the ROIO circular perimeter. This means 
that at the end of the computational process, individual lGI cortical maps reflect the amount 
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of cortex buried within the sulcal folds in the surrounding circular region. The method has 
been thoroughly described and validated (Schaer et al., 2008). 
 
2.3 Assessment of OCs 
Information on OCs was collected from hospital birth records. Subjects were born between 
the years of 1943 and 1982. Obstetric care in Sweden has been of high quality all this 
period, and the birth records were very detailed. The information was scored according to 
the McNeil-Sjöström scale (McNeil & Sjostrom, 1995) by a physician who was blinded to 
patient/control status and MRI-results (UKH). The McNeil-Sjöström scale rates OCs 
according to severity at an ordinal scale from 1-6, where severity level one signifies a “not 
harmful or relevant” event and 6 signifies “very great harm to or deviation in offspring”. The 
scale has been constructed for the use in studying the effect of OCs in clinical case-control 
studies in which individual complications (e.g. low birth-weight, prematurity or placental 
abruption) occur too infrequently to be assessed separately (McNeil et al., 1994). In the 
present study, the number of OCs with severity scores of 3 and above was calculated for 
each individual subject to form one continuous variable. Scores under 3 are considered to 
be not harmful to the foetus (Haukvik et al., 2010;McNeil & Sjostrom, 1995). Obstetric 
characteristics are presented in Table 1. 
 
2.4 Statistical analyses 
Statistical differences  in demographic and obstetric variables between patient and control 
groups were evaluated using Chi-Square tests, Independent Samples T-tests and Mann-
Whitney non-parametric tests in the SPSS version 16.0 (SPSS Inc, Chicago IL.). The main 
analyses were performed vertex-wise as well as with predefined cortical areas (parcellations) 
 
2.4.1 Vertex-wise analyses 
a) At first, vertex-wise analysis of case-control differences in lGI across the whole cortical 
mantle was conducted contrasting schizophrenia patients and healthy controls, with lGI as 
the dependent variable, and age and gender as covariates.  
 b) Thereafter, vertex-wise analyses with OCs as independent variable (with age and gender 
as covariates) and lGI as the dependent variable were conducted in patients and control 
subjects both separately and combined.  
The vertex-wise analyses were conducted with a general linear model within FreeSurfer, and 
a false discovery rate (FDR) of 0.05 was applied to correct for multiple comparisons 
(Genovese et al., 2002). 
 
2.4.2 Parcellation analyses 
a) Case-control differences of average lGI-values for 34 pre-defined cortical parcellations (41) 
in each hemisphere (total n=68), were investigated by multiple linear regression analyses 
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with the parcellation as the dependent variable, and diagnosis, age, and gender as 
independent variables.  
b) Thereafter, the relationship between OCs and average lGI in the same 68 parcellations 
was explored in the combined sample using multiple linear regression analyses with OCs, 
age, gender, and diagnosis as independent and each parcellation as dependent variables. 
The diagnosis*OCs interaction term was added to the analysis for the parcellations in which 
OCs were related to the lGI at p<0.05.  
All parcellation regression analyses were performed in SPSS, and Bonferroni correction was 
applied to control for the number of multiple regression analyses ( level 0.05/ 68 
parcellations). 
 
3. Results 
3.1 Demographic and obstetric variables 
Demographic variables were similar in patients and control subjects. There were no 
differences between patients and control subjects regarding number of OCs, or any of the 
other obstetric variables (Table 1). 
 
3.2.1 Vertex-wise lGI in patients versus controls (2.4.1 a) 
Schizophrenia patients displayed lower lGI than healthy control subjects in one cluster in 
the left parietal lobe and two clusters in the right hemisphere (in the temporal-, and frontal 
lobe) at a significance level of 0.01(Figure1). However, after FDR correction for multiple 
comparisons, there were no significant differences in lGI between patients and controls. 
 
3.2.2.Vertex-wise lGI in relation to OCs in patients and controls (2.4.1 b) 
In patients, increasing number of OCs was related to lower lGI in a large cluster in the left 
medial posterior temporal lobe, and in a smaller cluster in the left inferior frontal sulcus and 
gyrus (p<0.05, uncorrected) (Figure 2). In control subjects, OCs were related to lower lGI in a 
larger area in the left inferior frontal sulci and gyri (p<0.05); for this area, there was a 
similar inverse relationship between OCs-scores and lGI in patients and control subjects 
(albeit for a larger area in the control subjects) (Figure 2). When patients and control 
subjects were analyzed together, the lower lGI in the left inferior frontal sulci and gyri was 
related to increasing number of OCs (p<0.01) (Figure 2). After FDR correction for multiple 
comparisons the findings were non-significant.  
 
3.3.1 Case-control differences in average lGI in cortical parcellations (2.4.2 a) 
Patients displayed lower lGI values in the rostral middle frontal, precentral, postcentral, and 
bank of superior temporal gyrus parcellations bilaterally. In addition, patients demonstrated 
lower lGI in the left hemisphere supramarginal, superioparietal, middle temporal, and 
inferior temporal parcellations, and the right precuneus, pars opercularis, and isthmus 
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cingulate parcellations (all p values < 0.05). However, the findings were non-significant after 
Bonferroni correction for multiple comparisons of 68 parcellations 
 
3.3.2 The relationship between OCs and average lGI in cortical parcellations (2.4.2 b) 
In both schizophrenia patients and healthy controls, increasing number of OCs was 
significantly related to lower lGI in the left pars triangularis (p<0.0005) (Figure 3). This 
result remained significant after Bonferroni correction.  
Five other parcellations in the left hemisphere (fusiform, lateral occipital, parahippocampal, 
rostral middle frontal, and pars opercularis) displayed a similar relationship to OCs (Figure 
3), but these findings did not remain significant after Bonferroni correction for multiple 
testing (Table 2). There was no diagnosis*OCs interaction effect in either of 6 parcellations 
(data not shown). There were no significant relationships between OCs and lGI in the right 
hemisphere (Table 2).  
 
4. Discussion 
The main finding in the present study is that increasing number of OCs was significantly 
related to lower lGI in the left pars triangularis in both schizophrenia patients and healthy 
control subjects. A similar trend was also demonstrated for five other parcellations in the 
left hemisphere, whereas no relationship between OCs and lGI was demonstrated in the 
right hemisphere. This is the first time the relationship between OCs and a 3D- local 
gyrification index in schizophrenia has been investigated.  
 
Effects of OCs on cortical folding 
Studies of gyrification in premature infants have demonstrated increased temporal  
gyrification bilaterally as compared to term infants (Kesler et al., 2006), and higher sulcation 
index (a measure of cortical folding), when related to brain surface, in preterm intra-uterine 
growth restriction infants compared with “normal” preterm infants (Dubois et al., 2008). 
Although the present subject sample included three subjects born prematurely, the results 
are not directly comparable, as the range of obstetric severity is much larger in the present 
sample. However, the previous findings suggest that gyrification deviances may be related to 
adverse conditions during foetal brain development. 
 
Only one previous study has investigated the effect of OCs on gyrification in schizophrenia 
(Falkai et al., 2007). From the two-dimensional gyrification index in six coronal MRI sections 
(three in the frontal and three in the parietal lobe), Falkai and colleagues did not find any 
relationship between OCs and gyrification in schizophrenia patients. The methodological 
differences may explain why the results in the present study differ from those by Falkai and 
colleagues. In the present study, the 3D surface-based approach allowed searching for 
multiple local alterations in gyrification across the whole cortical mantle. It is worth noting 
that the same definition and categorization of OCs were applied, OCs being scored with the 
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McNeil-Sjöström scale in both studies. This increases the comparability of the studies, and 
furthermore supports the present use of a surface based local gyrification method to 
investigate cortical folding patterns. 
 
Smaller prefrontal and temporal cortical volumes have been reported in schizophrenia 
patients with a history of foetal hypoxia (Cannon et al., 2002). Both cortical folding patterns 
and cortical thickness affect cortical volume, but their relationship is uncertain. We have 
previously investigated the present subject sample for association between OCs and cortical 
thickness and found no association in schizophrenia patients or in healthy controls 
(Haukvik et al., 2009). Moreover, Schaer et al. have reported that congenital heart disease 
(presumed to cause lower oxygen delivery to the brain) in patients with 22q11 deletion 
syndrome was related to altered cortical folding patterns in the brain but not to cortical 
thickness (Schaer et al., 2009). Janssen et al. reported more widespread cortical thickness 
reductions than gyrification abnormalities in adolescent onset psychosis, and concluded 
that the cortical thickness reductions in schizophrenia appear to be caused by factors 
occurring after cortical folding is finished (Janssen et al., 2009). Taken together, the 
previous and the current findings suggest that cortical folding patterns may be a more 
robust brain morphological correlate of early neurodevelopmental aberrances than are 
measures of cortical thickness.  
 
Pars triangularis 
The relationship of OCs and lGI in the left pars triangularis is of particular interest, as pars 
triangularis together with pars opercularis are included under Broca’s area. Broca’s area is 
important to different aspects of neurocognitive functioning such as language formation 
(Bhojraj et al., 2009), semantic encoding (Demb et al., 1995), semantic retrieval (Badre & 
Wagner, 2007), syntactic processing (Friederici et al., 2003), and syntactic working memory 
(Fiebach et al., 2005).  Aberrations in neurocognitive domains related to Broca’s area have 
been reported in schizophrenia ((Mesholam-Gately et al., 2009) for review) but also in 
preterm/very low birth weight children ((arnoudse-Moens et al., 2009) for review), and in 
children suffering perinatal asphyxia (Stevens et al., 1999).  
 
Increased metric distortion (as an indirect measure of cortical displacement and 
convolution) in the left pars triangularis (Wisco et al., 2007), and reduced sulcal index in 
Brocas area (Cachia et al., 2008) have been described in schizophrenia patients as 
compared to healthy controls. In contrast, Janssen et al have reported no relationship 
between lGI and adolescent-onset-psychosis and control status in the pars triangularis by 
using the same lGI algorithm as in the present study (Janssen et al., 2009). In the pars 
opercularis which is located adjacent to pars triangularis, post-mortem findings 
demonstrated no abnormalities in laminar neuronal densities, glial density, cortical 
thickness, or somal size in schizophrenia patients as compared to healthy controls (Selemon 
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et al., 2003). In the present study, the same relationship between higher number of OCs and 
lower lGI was found in pars triangularis and in pars opercularis, but for pars opercularis the 
p-value of 0.021 did not remain significant after multiple comparisons control. The 
cytoarchitecture in pars opercularis and pars triangularis has been reported to be more 
similar than the other cortical parcellations (Amunts K & Zilles K, 2006), and consequently 
the post mortem findings (Selemon et al., 2003) may be also transferable to the pars 
triangularis. We can only speculate that if so, the present findings of no case control 
differences in the lGI in this area may mirror a cytoarchitecture not affected by case control 
status but, intriguingly, rather by a history of OCs which have a similar untoward effect on 
both schizophrenia patients and healthy controls.  
 
Parcellation versus vertex-wise analyses 
In the present study, the parcellation analysis demonstrated that the reduced lGI in the left 
pars triangularis was not related to schizophrenia diagnosis but to increasing number of 
OCs in both patients and controls. This corresponds to results from the uncorrected vertex 
wise analyses on the effects of OCs performed in patients and controls separately. In 
patients only, the uncorrected vertex-wise analyses demonstrated a relationship between 
increasing number of OCs and lower lGI in the left temporal lobe, corresponding to the 
parahippocampal, fusiform, and lingual parcellations which might suggest a weak 
relationship in this cortex region among patients. The findings were however negative after 
multiple comparisons control, and it is uncertain if they represent a potential differential 
effect of OCs on cortical folding in patients with schizophrenia and healthy controls in this 
area. That the relationship between OCs and cortical folding was significant only in the 
parcellation analysis, may be a result of different methods of correction for multiple 
comparisons, or it may suggest that subtle differences in lGI between groups are easier to 
detect when measured as average lGI over a larger area (such as the pre-defined 
parcellations). 
 
Case-control differences 
No statistically significant differences (after multiple comparisons control) in lGI were found 
between patients with schizophrenia and healthy controls in neither pars triangularis, in 
any of the other parcellations, or in the vertex wise analyses. Thus the results do not 
support our hypothesis that OCs would affect lGI in areas where patients had a different 
folding pattern than control subjects, and no definite conclusions as to whether or not the 
hypothesised case-control differences in cortical folding were attributed to OCs in the 
current sample could be drawn. However, in a larger study by our group of approximately 
200 schizophrenia patients and 200 controls, including the current subject sample, patients 
demonstrated significantly lower lGI in the left pericentral cortex (Nesvåg et al, in prep.). 
This finding corresponds to one of the areas where case-control differences that did not 
survive FDR control were found in the current study and provide some support that the 
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relationship between OCs and cortical folding is independent from putative case-control 
differences in the current subject sample. 
 
In conclusion, the present study demonstrates a statistically significant relationship 
between OCs and the local gyrification index with a higher number of OCs related to a lower 
gyrification index in the pars triangularis of the left brain hemisphere in both schizophrenia 
patients and healthy control subjects. A similar trend was found for five other cortical 
anatomical areas in the left hemisphere. The findings suggest that a relationship between 
OCs and cortical folding may be caused by factors shared by schizophrenia patients and 
healthy controls rather than factors related to schizophrenia alone. 
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Figure 1 
 
Differences in local gyrification between patients and control subjects at p< 0.01 co-varied 
for age and gender, without FDR correction. Within the coloured areas, patients 
demonstrate lower cortical folding than healthy control subjects. 
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Figure 2 
The effect of increasing number of obstetric complications on local gyrification in 
schizophrenia patients, healthy controls, and the combined sample, co-varied for age and 
gender at two different p-levels without FDR correction.  
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Figure 3 
The effect of increasing number of obstetric complications on average local gyrification in 
pre-defined cortical areas in the left hemisphere, co-varied for age, gender, and diagnosis, 
significant at p<0.05. The red area remains significant after Bonferroni correction for 
multiple test. The colour map represents B-values, corresponding p-values are listed in table 
2.  
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Table 1. Demographic and clinical characteristics in schizophrenia patients and healthy 
control subjects. 
 
 Patients (n=54) Controls (n=54) Statistics 
 Mean S.E. Mean S.E. Test-value p-value 
Age at MRI (years) 41.9 1.1 41.5 1.2 t=.28 ns 
Age at illness onset 
n=53 (years)  
24.9 0.8 na   na 
Duration of illness 
(years) 
16.8 1.3 na   na 
 Number % Number %   
Gender (male/female) 37/17 68/32 33/21 61/39 2=.65 ns 
Handedness n=105 
(right/left/ambidextr.)  
48/2/2 92/4/4 48/3/2 91/6/4 2=.19 ns 
Medication 
(typical/atypical/none) 
25/26/3 46/48/6 na   na 
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Table 2. Local gyrification index (lGI) of 68 paracellations in 54 schizophrenia patients and 
54 healthy controls. Linear regression model with age, diagnosis, gender, and continuous 
obstetric complications (OCs). Bolded p-values remain significant after Bonferroni control 
for multiple comparisons. 
 
Parcellation (Desikan) 
 
  Age Diagnosis Gender OCs 
Mean lGI S.E. p-value p-value p-value Effect (B), 
p-value 
lh_bankssts     3.3881 .01907 .004 .029 .038 ns 
lh_caudalanteriorcingulate 1.81832 .009010 ns ns .027 ns 
lh_caudalmiddlefrontal 3.00211 .014893 .004 ns ns ns 
lh_corpuscallosum 1.95189 .010382 ns ns ns ns 
lh_cuneus 2.74741 .017314 ns ns .006 ns 
lh_entorhinal 2.49633 .014219 ns ns <.0005 ns 
lh_fusiform 2.56096 .012122 .009 ns  <.0005 B=-.006, p=.011 
lh_inferiorparietal 3.09906 .014355 .001 ns ns ns 
lh_inferiortemporal 2.5795 .01137 .008 ns ns ns 
lh_isthmuscingulate 2.6629 .01936 ns ns .006 ns 
lh_lateraloccipital 2.43191 .011829 .001 ns .005 B=-.005, p=.037 
lh_lateralorbitofrontal 2.44943 .011551 .002 ns ns ns 
lh_lingual 2.63081 .015502 ns ns <.0005 ns 
lh_medialorbitofrontal 1.90665 .008340 ns ns ns ns 
lh_middletemporal 3.16071 .016529 ns .022 ns ns 
lh_parahippocampal 2.75893 .017231 ns       ns <.0005 B=-.009, p=.007 
lh_paracentral 2.18237 .010015 .004 ns .010 ns 
lh_parsopercularis 4.10656 .028911 ns ns .004 B=-.014, p=.021 
lh_parsorbitalis 2.68776 .017992 .006 ns ns ns 
lh_parstriangularis 3.50758 .026511 .001 ns .014 B=-.020, p<.0005 
lh_pericalcarine 2.66573 .017317 ns ns .001 ns 
lh_postcentral 3.38122 .015875 <.0005 .010 .006 ns 
lh_posteriorcingulate 2.09632 .012731 ns ns .010 ns 
lh_precentral 3.33364 .016091 <.0005 .022 <.0005 ns 
lh_precuneus 2.7341 .01716 ns ns .004 ns 
lh_rostralanteriorcingulate 1.90406 .009434 ns ns .044 ns 
lh_rostralmiddlefrontal 2.67035 .014785 <.0005 .048 ns B=-0.008, p=.007 
lh_superiorfrontal 2.0692 .00798 .001 ns ns ns 
lh_superiorparietal 2.8117 .01269 .001 .040       ns ns 
lh_superiortemporal 3.98287 .022661 ns ns <.0005 ns 
lh_supramarginal 3.45896 .016199 <.0005 .018 ns ns 
lh_frontalpole 1.89652 .009168 ns ns ns ns 
lh_temporalpole 2.21617 .012337 .040 ns ns ns 
lh_transversetemporal 4.62608 .030140 ns ns <.0005 ns 
rh_bankssts 3.42684 .023447 ns .006 .029 ns 
rh_caudalanteriorcingulate 1.89577 .008739 ns ns ns ns 
rh_caudalmiddlefrontal 2.99039 .017083 .001 ns .001 ns 
rh_corpuscallosum 2.00781 .008942 ns ns ns ns 
rh_cuneus 2.87261 .017198 ns ns .045 ns 
rh_entorhinal 2.47533 .012615 ns ns .005 ns 
rh_fusiform 2.50782 .010213 .041 ns <.0005 ns 
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rh_inferiorparietal 3.11019 .013846 <.0005 ns ns ns 
rh_inferiortemporal 2.49439 .009840 .032 ns .041 ns 
rh_isthmuscingulate 2.72958 .017948 ns .041 .027 ns 
rh_lateraloccipital 2.43136 .010828 .019 ns ns ns 
rh_lateralorbitofrontal 2.38719 .010534 .001 ns ns ns 
rh_lingual 2.67593 .014324 .034 ns .009 ns 
rh_medialorbitofrontal 1.95517 .008255 ns ns ns ns 
rh_middletemporal 3.09317 .017001 ns ns .022 ns 
rh_parahippocampal 2.73984 .013432 ns ns <.0005 ns 
rh_paracentral 2.2148 .01033 .019 ns .028 ns 
rh_parsopercularis 4.10933 .029237 ns .007 ns  ns 
rh_parsorbitalis 2.63202 .014480 .011 ns ns ns 
rh_parstriangularis 3.4628 .02504 .009 ns ns ns 
rh_pericalcarine 2.76753 .017489 .006 ns .016 ns 
rh_postcentral 3.35444 .017263 <.0005 .037 .030 ns 
rh_posteriorcingulate 2.11528 .011755 ns ns ns ns 
rh_precentral 3.29687 .016828 <.0005 .026 .002 ns 
rh_precuneus 2.8514 .01646 ns .015 .006 ns 
rh_rostralanteriorcingulate 1.97476 .009784 ns ns .023 ns 
rh_rostralmiddlefrontal 2.61373 .012540 <.0005 .035 ns ns 
rh_superiorfrontal 2.1030 .00780 <.0005 ns .003 ns 
rh_superiorparietal 2.8130 .01249 <.0005 ns ns ns 
rh_superiortemporal 3.95814 .029368 ns ns .001 ns 
rh_supramarginal 3.44792 .018830 <.0005 ns ns ns 
rh_frontalpole 1.93479 .008813 ns ns ns ns 
rh_temporalpole 2.18840 .010157 ns ns ns ns 
rh_transversetemporal 4.72057 .060423 ns  ns .013 ns 
      
    
Average local gyrification index for each parcellation 
Adjusted R square <0.1 for the linear regression model in this parcellation. 
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Abstract 
Background: Smaller hippocampal volume has repeatedly been reported in 
schizophrenia patients. Obstetric complications (OCs) and single nucleotide 
polymorphism (SNP) variation in schizophrenia susceptibility genes have independently 
been related to hippocampal volume. We investigated putative independent and 
interaction effects of severe hypoxia-related OCs and variation in four hypoxia-regulated 
schizophrenia susceptibility genes (BDNF, DTNBP1, GRM3 and NRG1) on hippocampal 
volume in schizophrenia patients and healthy controls.  
Methods: Clinical assessment, structural MRI-scans, and blood samples for genotyping 
of 32 SNPs were obtained from 54 schizophrenia patients and 53 control subjects. 
Information on obstetric complications was collected from original birth records.  
Results: Severe OCs were related to hippocampal volume in both patients with 
schizophrenia and healthy control subjects. Of the 32 SNPs studied, effects of severe 
OCs on hippocampal volume were associated with allele variation in GRM3 rs13242038, 
but the interaction effect was not specific for schizophrenia.  SNP variation in any of the 
four investigated genes alone did not significantly affect hippocampal volume.  
Conclusions: The findings suggest a gene-environment (G x E) interaction between 
GRM3 gene variants and severe obstetric complications on hippocampus volume, 
independent of a diagnosis of schizophrenia. Due to the modest sample size, the results 
must be considered preliminary and require replication in independent samples. 
 
Key words: GRM3, hippocampus, hypoxia-regulated genes, obstetric complications, 
schizophrenia. 
 
Abbreviations 
BDNF- brain-derived neurotrophic factor 
DTNBP1- dysbindin 
GRM3- metabotropic-glutamate-receptor 3 
ICV –intracranial volume 
MRI- magnetic resonance imaging 
NRG1- neuregulin1 
OCs- obstetric complications 
HCV- hippocampal volume 
LD – Linkage disequilibrium 
ICC – inter class correlation 
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1. Introduction 
Schizophrenia is a severe mental illness with a prevalence of about 0.7% worldwide 
(Saha et al., 2005). The illness has a strong genetic component, with an estimated 
heritability of 80% (Sullivan et al., 2003). However, most patients suffering from 
schizophrenia have no affected relative, and multiple environmental effects modify 
schizophrenia liability (Tandon et al., 2008). The exact mechanisms underlying 
schizophrenia pathology are uncertain, but disturbances of dopamine and glutamate 
transmission are of importance (Howes & Kapur, 2009;Stone et al., 2007). 
 
Obstetric complications (OCs), occurring during pregnancy, delivery, and the neonatal 
period, are well documented risk factors for schizophrenia (Cannon et al., 2002;Dalman 
et al., 2001;Geddes et al., 1999;Hultman et al., 1999). Foetal hypoxia may cause 
damage to the developing brain (Verdoux & Sutter, 2002) and increase the susceptibility 
for later development of schizophrenia (Marenco & Weinberger, 2000;Rapoport et al., 
2005). In animal models, OCs have been demonstrated to affect both the structure of 
the brain and the behavior of the offspring ((Boksa, 2004) for review). 
 
Through extensive research efforts over the last years, a number of genes have been 
suggested to contribute to schizophrenia susceptibility (Harrison & Weinberger, 2005). 
Several of the suggested susceptibility genes are involved in neurodevelopment (Arnold 
& Rioux, 2001). A high proportion of the genes are regulated by hypoxia-ischemia 
(Schmidt-Kastner et al., 2006), e.g.  neuregulin 1 (NRG1) and dysbindin (DTNBP1), 
which both affect neural migration and synaptic development (Harrison & Weinberger, 
2005;Numakawa et al., 2004); brain-derived neurotrophic factor (BDNF), which 
influences pre- and postnatal neuronal survival, differentiation, synaptogenesis, and 
maintenance (Webster et al., 2006); and the metabotropic-glutamate-receptor 3 
(encoded by the GRM3 gene), which is expressed in neuronal stem cells (Harrison et al., 
2008;Melchiorri et al., 2007). Thus variation in hypoxia-regulated genes, in combination 
with severe OCs leading to hypoxia, have been hypothesized to be of importance to the 
etiology of schizophrenia, and there is some evidence that the effect of severe OCs on 
disease risk is modified by SNP variation in BDNF, DTNBP1, and GRM3 (Nicodemus et 
al., 2008). 
 
MRI-studies have consistently shown that schizophrenia patients have a reduced 
hippocampal volume (HCV) (see (Honea et al., 2005) for review), and nucleotide 
variations e.g. in genes regulated by hypoxia have been associated with volume changes 
in the hippocampus (e.g. the BDNF gene) and other brain regions (e.g. NRG1, catechol-o-
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methyl transferase (COMT)) in patients, see (van Haren et al., 2008) for review. 
Interestingly, hippocampal volume has been reported to be smaller in schizophrenia 
patients with a history of OCs and foetal hypoxia, as compared to patients without such 
a history (Ebner et al., 2008;McNeil et al., 2000;Schulze et al., 2003;Stefanis et al., 
1999;van Erp et al., 2002). This is consistent with results from experimental animal 
models in which prenatal hypoxic insults have been demonstrated to result in 
hippocampal CA1-region neuronal damage (Rees & Inder, 2005), and birth related 
hypoxia to result in reduced hippocampal cell number (Boksa, 2004) 
 
As hypoxia is a core feature of OCs and a strong modifier of gene expression (Schmidt-
Kastner et al., 2006), we hypothesized that the effect of OCs on HCV could be modified 
by variation in hypoxia-regulated genes. Consequently, in the present study of 
schizophrenia patients and healthy control subjects, we explored if 1) there was a 
statistically significant relation between a history of hypoxia-related severe OCs and 
hippocampal volume, and 2) if such a putative relationship was modulated by allele 
variation in four genes that are regulated by hypoxia and associated with schizophrenia 
(NRG1, BDNF, GRM3 and DTNBP1).  
 
2. Methods: 
2.1 Subject characterization 
This study was part of the Human Brain Informatics Project (HUBIN), Karolinska 
Institutet, Stockholm, Sweden. HUBIN is a comprehensive database of genetic, brain 
morphological, neuropsychological, and clinical information obtained from 
schizophrenia patients and healthy subjects. The subject inclusion took place between 
1999 and 2003. All participants gave written informed consent. The project was 
approved by the Research ethics committee at Karolinska Institutet and the Swedish 
Data Inspection Board (“Datainspektionen”). The study was performed in accordance 
with the Helsinki Declaration. 
 
The subject sample consisted of unrelated Caucasian men and women currently 
residents in the Stockholm Area, and has previously been described in detail (Haukvik 
et al., 2009;Jonsson et al., 2006). Briefly; invited patients from the out-patients clinic 
underwent a comprehensive clinical assessment protocol using validated operational 
instruments (Ekholm et al., 2005;Vares et al., 2006) including verification of diagnosis 
by a trained psychiatrist (EGJ). Patients fulfilled DSM-III-R or DSM-IV criteria for 
schizophrenia or schizoaffective disorder. Exclusion criteria were a history of head 
trauma with loss of consciousness > 5 minutes, current diagnosis of substance abuse, 
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and/or somatic disorders affecting brain function. The healthy control subjects were 
drawn from a population register or recruited among hospital staff; they were 
interviewed by a trained psychiatrist and were found to have no current or previous 
psychiatric illness. 
 
The present analysis included all subjects in the HUBIN-project with a diagnosis of 
schizophrenia (n = 50) or schizoaffective disorder (n=4) and 53 age-matched healthy 
controls for whom obstetric records, DNA and high resolution MRI scans were available. 
Subject characterization and demographics are listed in Table 1. 
 
2.2 MRI  
2.2.1  MRI scan acquisition  
Magnetic resonance images were obtained at the MR Research Centre at Karolinska 
Institutet, Stockholm, Sweden, using a 1.5 Tesla GE signa Echo-speed (Milwaukee, 
Wis., USA) scanner. T1-weighted images, using a three-dimensional spoiled gradient 
recalled (SPGR) pulse sequence, were acquired with the following parameters; 1.5 mm 
coronal slices, no gap, 35° flip angle, repetition time (TR) = 24 ms, echo time (TE) = 6.0 
ms, number of excitations (NEX) = 2, field of view (FOV) = 24 cm, acquisition 
matrix = 256 × 192. T2-weighted images were acquired with the following parameters; 
2.0 mm coronal slices, no gap, TR = 6,000 ms, TE = 84 ms, NEX = 2, FOV = 24 cm, 
acquisition matrix = 256 × 192. All scans included were judged visually to be without 
obvious motion artefacts. A trained neuroradiologist evaluated all scans to be without 
gross pathology.   
 
2.2.2. MRI scan post processing using FreeSurfer software 
Hippocampal volume was quantified by automated processing of T1-weighted MR 
images with the FreeSurfer v 3.0.2 software (http://surfer.nmr.mgh.harvard.edu) 
(Figure 1a). With this method, a neuroanatomical label is automatically assigned to 
each voxel in the MRI volume based on probabilistic information estimated 
automatically from a manually labelled training set (Fischl et al., 2002). The automatic 
measures define the whole hippocampal formation (including the fimbria) as 
hippocampus (Makris et al., 1999). HCVs as obtained by FreeSurfer have been reported 
to be as reliable as manual delineations by experts when compared to different manual 
delineations by experts (Fischl et al., 2002) 
 
2.2.3 MRI scan post processing using BRAINS software 
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Brain tissue segmentation was also performed using the software suite BRAINS 
(Andreasen et al., 1993) from T1 and T2-weighted MR images re-sliced to 1-mm3 voxels 
in standardized space. Using an automatic tissue classification procedure all brain 
tissue was classified in the following tissue class volumes: grey matter, white matter, 
cerebrospinal fluid, and venous blood (Agartz et al., 2001;Agartz et al., 2006;Harris et 
al., 1999). Measurements of intracranial volume (ICV) obtained using BRAINS were 
used to correct for inter-individual differences in head size. 
 
To examine to what extent our results depended on the method of quantifying brain 
volume, and to facilitate comparisons with the results from previous studies (Ebner et 
al., 2008;McNeil et al., 2000;Schulze et al., 2003;Stefanis et al., 1999;van Erp et al., 
2002), we also examined the association between severe OCs and HCV using manual 
hippocampal delineation (Figure 1b). Our research group had previously delineated 
hippocampal grey matter (i.e. the hippocampus proper and dentate gyrus) from T1-, T2- 
and segmented MR images (Agartz et al., 2006), and measurements were available in a 
randomly chosen subset (n=60, 33 patients and 27 control subjects) of the total subject 
sample (n=107). All manual delineations were performed by one person. The intra-rater 
reliability (ICC) for two separate delineations of 10 randomly selected brains was >0.98 
for both the left and the right hippocampus. The demographic and clinical 
characteristics (including obstetric variables) of this group did not significantly differ 
from the total subject sample (n=107) (data not shown). 
 
2.3 Obstetric complications  
Information on OCs was collected from hospital birth records and rated according to the 
McNeil-Sjöström scale by one physician (UKH) who was blinded to patient/control 
status and to the results from genotyping and MRI. The inter-rater reliability (interclass 
correlation) between two physician raters (one of whom was UKH) for 62 of the birth 
records was 0.93. 
The McNeil-Sjöström scale includes several hundred items of potential harm to the 
foetus, each classified according to severity at an ordinal scale from 1-6. The scale has 
been validated for use in schizophrenia case-control studies (McNeil et al., 1994). In the 
present study, severe OCs were considered present in subjects who had experienced 
one or more complications of grade five or six, whereas subjects with complications of 
grade four and below were classified as not having had severe OCs, in congruence with 
the definition used by Nicodemus et al. (Nicodemus et al., 2008). A complication of 
grade five is defined as “potentially clearly greatly relevant/harmful” (e.g. severe 
preeclampsia or foetal asphyxia), and a complication of grade six is defined as a 
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complication that causes “very great harm to or deviation in offspring” (e.g. eclampsia, 
offspring hypoxic-ischemic cerebral injury). In the present subject sample, the recorded 
severe OCs were as follows: Prolonged birth (13 subjects), meconium-stained amniotic 
fluid (5 subjects), asphyxia (3 subjects), prematurity < 32 weeks (3 subjects), placental 
abruption (2 subjects), bleeding during first trimester (2 subjects), meconium aspiration 
syndrome (2 subjects), prematurity < 35 weeks (2 subjects), twin transfusion syndrome 
(1 subjects), mid-forceps delivery (1 subject), small for gestational age (1 subject), acute 
caesarean section (1 subject), and low birth weight (1 subject). 17 subjects were 
exposed to one severe OC, and the maximum number was five complications in one 
subject. The obstetric variables are listed in Table 1. 
 
2.4 Genotyping 
Based on previous literature, 32 schizophrenia-related single nucleotide polymorphisms 
(SNPs), located in four hypoxia-regulated genes, were selected for genotyping (Table 2). 
Genomic DNA was extracted from whole blood samples, and SNPs located in DTNBP1, 
GRM3 and NRG1 genes were genotyped at the SNP Technology Platform at Uppsala 
University and Uppsala University Hospital, Sweden (www.genotyping.se), using the 
Illumina BeadStation 500GX and the 1536-plex Illumina Golden Gate assay (Illumina 
Inc., San Diego, CA, USA) (Jonsson et al., 2009). The four BDNF SNPs were genotyped 
by pyrosequencing (Ahmadian et al., 2000) or cleavage with restriction enzymes as 
previously described (Jonsson et al., 2006). The sample success rate was on average 
99.8% for the genotyped SNPs. 
 
2.5 Statistical analyses  
To examine whether the history of severe OCs affects HCV in schizophrenia patients 
and healthy control subjects, and to what extent such effects depended on allele 
variation in the four genes, the HCV was analysed with a linear model in Proc MIXED in 
the SAS software (SAS/STAT® software, version 9.1.3, SAS institute Inc., Cary, NC). 
  
First, we performed a preliminary analysis on the HCV of the left and right hemisphere 
without SNP markers. In this analysis, diagnosis (schizophrenia vs. control), severe OCs 
(presence vs. absence), the interaction between diagnosis and OCs, intracranial volume, 
age at MR scanning, and hemisphere side were treated as fixed factors, whereas 
individual was treated as a random factor. To test whether the effects of fixed factors 
differed between hemispheres, all interactions with hemisphere were included in the 
original model. Residuals were approximately normally distributed, as assessed by the 
Anderson-Darling test (p-values > 0.25).  
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Since the disease effect did not vary with presence/absence of severe OCs (p-values for 
diagnosis*OCs, and diagnosis*OCs*hemisphere were 0.25 and 0.77, respectively), the 
interaction between diagnosis and OCs was excluded from the statistical model. 
Moreover the effects of diagnosis, OCs, intracranial volume, and age at MR scanning on 
hippocampal volume did not differ significantly between the right and left hemispheres 
(p-values for interaction effects with hemisphere were  0.42). Consequently, further 
analyses of HCV were carried out on the average of measurements from the left and 
right hemisphere.  
 
Second, we used a linear model to carry out single marker allele association of the 
hippocampal volume (as obtained by FreeSurfer, n=107) including the number of minor 
alleles (a) and excluding hemisphere in the above model for each SNP separately.  To 
test if the effect of the disease and/or the effect of severe OC on hippocampal volume 
depended on genetic background, we included the two-way interactions between these 
factors and the minor allele count. Correction for multiple testing of allele associations, 
and their interactions with affection and OC status, was done by randomly permuting 
genotype among individuals 1000 times and re-analyzing the permuted data (Westfall & 
Young, 1993). Thus genotypes and phenotypes were decoupled keeping the original LD 
structure of the genetic markers and the covariance structure of phenotypes intact in 
each permuted data set. The adjusted p-value was defined as the fraction of 
permutations where the minimum p-value from allele associations, (or from its 
interaction with severe OC), was less than, or equal to, the minimum p-value in the 
original data. Hardy–Weinberg (HW) equilibrium of SNPs was tested in affected and 
controls using Fisher’s exact test as implemented in PEDSTATS (Wigginton & Abecasis, 
2005).  
 
For a random sub-sample (n= 60) of the study-group, the volume of hippocampal grey 
matter had been determined by manual delineation. For each individual, HCVs for the 
left and right hemisphere were combined, and the Pearson correlation and partial 
correlation coefficients (correcting for the intracranial volume) were calculated between 
manually and automatically delineated HCVs. In addition, we used mixed linear models 
to test whether the effects of diagnosis, OCs, and the interaction between OCs and 
RS13242038 on HCV depended on method of delineation (manual/automatic). In these 
analyses diagnosis, OCs, intracranial volume, age at MRI, number of minor alleles of 
RS13242038, and delineation method were considered as fixed factors, and individual 
as a random factor. The differences in HCV-response due to delineation method were 
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tested by the interaction effects between method of delineation and the other fixed 
factors. To account for differences in reliability of methods, a separate residual variance 
was used for manually and automated HCV measurements, respectively. 
 
3. Results 
3.1 Case-control differences in OCs 
The frequency of severe OCs was similar in schizophrenia patients and healthy controls 
(2=0.34, df 1, p=0.54), and there were no differences observed in obstetric variables 
between the two groups (Table 1). However, the power to detect a true association 
between OCs and diagnosis, corresponding to an odds-ratio of 2.0 (Clarke et al., 2006), 
was limited (power<0.40, given a OCs frequency of 23%).  
 
3.2  Automated HCV measures  
Patients with schizophrenia demonstrated, on the average, 5% smaller hippocampal 
volume than healthy control subjects, and this reduction was present in both the left 
and right hemispheres (p=0.001) (Fig 2a). The HCV was on the average larger in 
individuals who had experienced severe OCs, as compared to individuals who had no 
experience of such events (p=0.048) (Fig 2a); the average effect was 3.6% and the 
response was similar in both hemispheres (pOCs*hemisphere=0.42). The effects of diagnosis 
and of severe OCs on HCV appeared to be independent of each other, and the 
interaction between the two factors was not statistically significant (pdiagnosis*OCs=0.25, 
pdiagnosis*OCs*hemisphere=0.77). Further analysis was thus conducted on the mean of the left 
and right HCVs, assuming no interaction effects between diagnosis and OCs on HCV 
measurements.  
 
3.3 SNP effects from the automated segmentation 
We found evidence of the effect of severe OCs on hippocampal volume (n=107) to be 
dependent on the genotype of the GRM3 rs13242038 marker (Table 2) and this 
interaction effect was significant after correction for multiple testing (p=0.014). The 
larger hippocampal volumes observed in individuals with severe OC largely overlapped 
with the presence of one or two rs13242038-T alleles (Figure 2b).  
 
HCV was not consistently associated with any of the genotyped SNPs across OC and 
affection states (a, Table 2). Nor did we find any evidence for allele association varying 
with diagnosis (a*diagnosis, Table 2). One DTNBP1 marker (rs1011313) showed a 
tendency to be associated with HCV, and three additional markers in DTNBP1, GRM3 
and NRG1 (rs2743852, rs917071, rs2954041) showed a tendency for an allele 
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association that depended on disease status. Considering the large number of tests 
conducted, these signals were close to expectations from random variation, and the 
multiple-test corrected p-values for the most significant allele association (rs1011313) 
and disease interaction (rs917071) were 0.22 and 0.33, respectively.   
 
3.4 Comparison of automated and manual HCV measures  
The manually delineated volume of hippocampal grey matter was approximately three 
times smaller than the automatically derived measurements (including white matter); 
the HCVs were (mean± SE) 1.26 ±0.03 and 4.36±0.05 cm3 respectively. There was an 
overall correlation of HCV measurements derived by the two methods (r=0.52), which 
was partly explained by the intracranial volume (rpartial correlation = 0.41). As in the full 
sample, the HCV of patients was consistently smaller than that of controls in the sub-
sample (4.6%, p=0.037), and the difference was consistent in both automatic and 
manually derived volumes (pdiagnosis*method = 0.51). 
The effect of severe OCs on HCV clearly differed between manual and automatic 
measurements (pOCs*method = 0.02); automatically-derived HCV were larger in individuals 
who had experienced severe OCs (3.1%) than in individuals who had no such 
experience, whereas manually-derived volume of hippocampal grey matter was smaller 
in individuals with severe OCs (-5.9%), compared with the remaining subjects. The joint 
analysis of manually and automatically derived HCV confirmed that the effect of severe 
OC on HCV was dependent on rs13242038 genotype (pOCs*genotype= 0.004), and indicated 
that the interaction effect between OCs and the GRM3 locus differed between HCV 
measurements (pOCs*genotype*method = 0.016, Fig 3). That is, for automatically-derived 
measurements, the larger HCV volumes associated with severe OCs were only evident in 
individuals carrying the rs13242038 T-allele (p=0.026), whereas reduction in 
hippocampal grey matter associated with severe OC was only evident in individuals who 
were homozygous for the rs13242038 C-allele (p=0.041).  
 
4. Discussion 
This is the first study to examine the association of hippocampal volumes with OCs and 
molecular genetic markers in schizophrenia patients and healthy control subjects. The 
main finding was that the effect of severe OCs on hippocampal volume is modified by 
allele variation in the hypoxia-regulated gene GRM3 in both schizophrenia patients and 
healthy control subjects. Due to the modest sample size, results must be interpreted 
with caution. 
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Glutamate is an excitatory neurotransmitter. It is widely distributed throughout the 
brain, and has excitotoxic properties when present in high concentrations. GRM3 
encodes the group II metabotropic glutamate receptor mGluR3, which is involved in 
glutamate transmission, glial function, and neuroprotection, see (Harrison et al., 2008) 
for review.  The receptor is expressed in several neuron populations including the 
myelin producing oligodendrocytes (Harrison & Weinberger, 2005). mGluR3 is 
expressed in the hippocampus (Lyon et al., 2008), and receptor expression has been 
reported to be altered following transient brain ischemia (Raghavendra, V et al., 2002). 
In mice antenatal hypoxia causes a 2-4 fold reduction in mGluR3 expression, and the 
down-regulation in gene activity is linked to a decreased vulnerability of hypoxia-
induced white matter damage (Fontaine et al., 2008). This response is not found in rats, 
which may suggest that genetic factors underlie GRM3 regulation and the susceptibility 
to white matter damage in rodents (Fontaine et al., 2008). We can only speculate that 
our results could represent human correlates to the observations from animal models. 
 
In the present study we observed that hippocampal volume, as obtained by the 
automated FreeSurfer software, was on average larger in individuals who had 
experienced severe OCs than in individuals without such experience. These results were 
in contrast with the previous literature,  where OCs have been associated with smaller 
hippocampal volumes in similar clinical samples (Ebner et al., 2008;McNeil et al., 
2000;Schulze et al., 2003;Stefanis et al., 1999;van Erp et al., 2002). The discrepancy 
between the results in this and previous studies could be due to differences in the 
definition of the hippocampal borders. We used a fully automated procedure to quantify 
the volume of the hippocampal formation (Fischl et al., 2002;Makris et al., 1999), a 
procedure that included the white matter (e.g.  fimbria)  in proximity of the 
hippocampus proper/dentate gyrus, whereas all previous studies were based on 
narrower definitions including mainly hippocampal grey matter (Ebner et al., 
2008;McNeil et al., 2000;Schulze et al., 2003;Stefanis et al., 1999;van Erp et al., 2002). 
Thus our results may indicate that severe OCs affect hippocampal white matter 
differently from hippocampal grey matter. To examine this possibility, we reanalyzed a 
subset of our sample (60 individuals) for whom we had manual quantifications of 
hippocampal grey matter volume (Agartz et al., 2006). In this sub-sample, severe OCs 
were associated with smaller hippocampal grey matter volume in individuals who were 
homozygous for the rs13242038 c-allele. Findings from animal models provide some 
support for a differential effect of severe OCs on grey and white matter. Both neuronal 
degeneration in the hippocampal CA1 region (grey matter) (Boksa, 2004;Rees et al., 
2008), and hippocampal gliosis (white matter) (Bernert et al., 2003) have been reported 
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following perinatal asphyxia. In addition, prenatal hypoxia has been demonstrated to 
exert a different effect on grey and white matter depending on the timing as well as the 
severity of the hypoxic insult (Rees & Inder, 2005).  
 
The association between OCs and hippocampal volume was similar in the patients with 
schizophrenia and the healthy control subjects. This is in disagreement with previous 
clinical studies reporting smaller hippocampal volumes with OCs/hypoxia in patients, 
but not in healthy siblings (van Erp et al., 2002), co-twins (McNeil et al., 2000) or 
independent controls (Schulze et al., 2003;Stefanis et al., 1999;van Erp et al., 2002). 
Our findings suggest instead that hippocampal vulnerability to severe OCs is influenced 
by factors independent of those related to schizophrenia pathogenesis; the effect may be 
modified by SNP variation in genes that are associated with schizophrenia risk (e.g. the 
GRM3 gene) but also occur in subjects without the illness. This is consistent with the 
findings by Ebner and co-workers, who reported that the association between OCs and 
reduced hippocampal volume also was present in relatives of schizophrenia patients 
(Ebner et al., 2008). Furthermore, severe OCs were equally distributed in schizophrenia 
patients and healthy controls. This is in contrast to large epidemiological studies 
(Dalman et al., 2001;Hultman et al., 1999), but in line with previous MRI studies of 
similar subject sample size as the current study (Ebner et al., 2008;Schulze et al., 
2003;van Erp et al., 2002).  
 
Limitations in the current study include the relatively small subject sample for the 
analyses of gene effects.  The combined number of GRM3 rs13242038  T allele carriers 
who had experienced severe OC was 9. It is also difficult to interpret possible functional 
consequences of the observed gene  OC interaction as the rs13242038 polymorphism 
is located in the first intron of the GRM3 gene, with no known function.  Nevertheless, it 
is possible that the SNP is in linkage disequilibrium with sequence variation influencing 
the transcription (or splicing) of the gene. If the minor rs13242038 allele is linked to a 
functional variant of GRM3, our results could lead us to hypothesize that: 1) naturally 
occurring genetic variants of GRM3 (in LD with the rs13242038-T allele), causing 
reduced expression/function of the receptor, decrease the susceptibility to grey matter 
damage associated with severe OCs, and 2) severe OCs stimulate white-matter growth 
in hippocampal areas, independently of GRM3 receptor variation. This could provide an 
alternative explanation as to why the results in hippocampal volume differ between 
manually- (only grey matter) versus automatically- (including white matter) obtained 
volume measures.     
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In this study, we have observed a statistical gene-environment interaction which is 
biologically plausible. However, the findings are preliminary and must be interpreted 
with care. The current approach can be refined and used in studies with better-powered 
subject samples in future attempts to disentangle genetic and environmental 
interaction effects on brain structure. 
 
Conclusion 
Severe OCs were related to hippocampal volume in both patients with schizophrenia 
and healthy control subjects, and the effect of severe OCs on hippocampal volume 
showed an association with allele variation in GRM3 rs13242038. The present study is 
the first to explore and report a possible statistical interaction effect between OCs and 
molecular genetic markers on hippocampal volume. Replication in independent samples 
is warranted.  
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Figure 1. Delineated right hippocampal volume from segmented images from FreeSurfer 
(A) based on a T1- weighted image, and manually (BRAINS) (B) from T1- and T2-
weighted images, from the same slice and scan of one person. 
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Figure 2. Automatically obtained hippocampal volume (HCV) (cm3) in schizophrenia 
patients and healthy control subjects with and without a history of severe obstetric 
complications (n=107) (A), and mean HCV in the combined group according to allele 
variation in GRM3 rs13242038 and presence/absence of severe OCs (B). 
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Figure 3. Manually and automatically obtained hippocampal volumes (cm3) in 
schizophrenia patients and healthy control subjects combined (n= 60), grouped 
according to allele variation in GRM3 rs13242038 and presence/absence of severe 
obstetric complications. 
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Table 1. Demographic, clinical, and obstetric variables in patients with schizophrenia 
and healthy control subjects 
 
                                                 
1 Antipsychotic treatment. Number of  individuals receiving each type of medication 
2 Number of individuals with one or more complications of grade 5 or 6. 
 
 Patients (n=54) Controls (n=53) Statistics 
 mean (SD) range mean (SD) range test value p-value 
Age at MRI 41.9 (8.0) 25-57 41.4 (9.0) 19-56 t=0.289,df 105 0.77 
Age at onset 24.9 (5.6) 15.9-39.5      
Duration of 
illness 
16.8 (9.3) 0.4-41.1     
Birth weight (g) 3494 (635) 1770-5630 3393 (670) 1460-
4720 
t=0.798,df 105 0.43 
Head 
circumference 
(cm) (n=104) 
33.8 (1.5) 30-37 33.7 (1.6) 28-36 t=0.191,df 102 0.85 
Gestational age 
(weeks) 
39.2 (1.9) 32-42 39.3 (2.3) 31-43 t=-0.200,df 
105 
0.84 
Maternal age 
(years) 
27.5 (5.6) 17-43 28.1 (5.4) 19-39 t=0.541,df 105 0.59 
 Number % Number %   
Gender       
-male/female 37/17 68/32 33/20 62/38 

2=0.463, df 1 0.50 
Medication1       
-none/typical/ 
atypical 
3/25/26 6/46/48     
Severe OCs2 15 28 12 23 

2=0.37,df 1 0.54 
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Table 2. Association between hippocampal volume and SNP variation in four hypoxia-
regulated genes. Minor allele frequencies (MAF) and test for Hardy-Weinberg 
equilibrium (HWE) are listed for patients affected with schizophrenia and control 
individuals separately. P-values for an allele association (a) and its interactions with 
severe OCs (aOC) and affection state (aScz) are listed for the combined sample. 
 
 
        MAF   
HWE (p-
values)   
Allele association (p-
values) 
Gene SNP alleles   Ctrl Scz   Ctrl Scz   a aOC adiagnosis 
DTNBP1 rs12524251 A/G  0.11 0.09  1.00 0.37  0.52 0.36 0.49 
 rs760666 G/A  0.23 0.26  0.71 1.00  0.42 0.14 0.74 
 rs2619539 C/G  0.49 0.52  0.17 0.18  0.95 0.98 0.82 
 rs3213207 T/C  0.15 0.17  0.58 1.00  0.08 0.44 0.53 
 rs1011313 C/T  0.10 0.08  0.08 0.30  0.01 0.34 0.97 
 rs2619528 C/T  0.25 0.26  0.71 0.48  0.10 0.29 0.71 
 rs2619522 A/C  0.25 0.26  0.71 0.48  0.10 0.29 0.71 
 rs1018381 G/A  0.09 0.09  1.00 1.00  0.85 0.44 0.32 
 rs909706 C/T  0.37 0.33  0.14 1.00  0.21 0.67 0.91 
 rs2743852 G/C  0.10 0.09  1.00 1.00  0.30 0.43 0.04 
 rs2619538 T/A  0.49 0.44  1.00 0.42  0.66 0.53 0.97 
GRM3 rs187993 T/G  0.35 0.23  0.37 0.44  0.51 0.39 0.18 
 rs13242038 C/T  0.21 0.27  1.00 0.73  0.72 0.001 0.74 
 rs917071 C/T  0.19 0.37  0.67 0.56  0.64 0.04 0.03 
 rs6465084 A/G  0.19 0.30  0.67 0.75  0.16 0.41 0.44 
 rs1468412 A/T  0.19 0.32  1.00 0.13  0.68 0.16 0.83 
NRG1 SNP8NRG221 T/C  0.40 0.35  0.26 0.77  0.98 0.76 0.53 
 SNP8NRG241 G/T  0.40 0.41  0.26 0.57  0.82 0.96 0.53 
 rs6994992 C/T  0.43 0.35  0.78 0.77  0.93 0.38 0.56 
 rs1354334 C/A  0.38 0.36  0.78 0.14  0.43 0.88 0.32 
 rs1503488 G/A  0.28 0.24  1.00 0.71  0.55 0.91 0.49 
 rs701955 C/G  0.28 0.24  1.00 0.71  0.68 0.82 0.62 
 rs776401 T/C  0.46 0.39  1.00 0.27  0.35 0.98 0.88 
 rs1481617 A/T  0.46 0.39  1.00 0.27  0.35 0.98 0.88 
 rs3924999 G/A  0.39 0.39  0.77 0.09  0.38 0.18 0.27 
 rs2954041 G/T  0.04 0.06  1.00 1.00  0.72 0.83 0.01 
 NRG1_EXON1 G/T  0.03 0.01  1.00 1.00  0.17 0.48 0.50 
 rs10503929 T/C  0.21 0.17  1.00 0.32  0.89 0.25 0.16 
BDNF rs16917204 G/C  0.16 0.17  0.10 0.14  0.81 0.55 0.63 
 rs6265 G/A  0.19 0.19  0.36 1.00  0.55 0.21 0.60 
 rs11030101 T/A  0.45 0.43  0.11 0.27  0.46 0.63 0.93 
  C270T C/T   0.05 0.05   1.00 1.00   0.51 0.15 0.91 
 
 
